TerrAscend (TSNDF) 10-Q 8 Aug 24 2024 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Aug. 07, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Registrant Name	TERRASCEND CORP.
Entity Central Index Key	0001778129
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		291,513,055
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	021-340690
Entity Incorporation, State or Country Code	A6
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	77 City Centre Drive
Entity Address, Address Line Two	Suite 501 - East Tower
Entity Address, City or Town	Mississauga
Entity Address, State or Province	ON
Entity Address, Country	CA
Entity Address, Postal Zip Code	L5B 1M5
City Area Code	717
Local Phone Number	610-4165
Document Quarterly Report	true
Document Transition Report	false

Unaudited Interim Condensed Con

Unaudited Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 27,378	$ 22,241
Restricted cash	3,113	3,106
Accounts receivable, net	16,799	19,048
Investments	1,737	1,913
Inventory	51,009	51,683
Prepaid expenses and other current assets	4,771	4,898
Total current assets	104,807	102,889
Non-current assets
Property and equipment, net	193,340	196,215
Deposits	284	337
Operating lease right of use assets	41,645	43,440
Intangible assets, net	212,515	215,854
Goodwill	106,929	106,929
Other non-current assets	724	854
Total non-current assets	555,437	563,629
Total assets	660,244	666,518
Current liabilities
Accounts payable and accrued liabilities	46,918	49,897
Deferred revenue	4,699	4,154
Loans payable, current	15,946	137,737
Contingent consideration payable, current	2,632	6,446
Operating lease liability, current	2,330	1,244
Derivative liability, current	899	0
Lease obligations under finance leases, current	93	2,030
Corporate income tax payable	3,184	4,775
Other current liabilities	756	717
Total current liabilities	77,457	207,000
Non-current liabilities
Loans payable, non-current	171,926	61,633
Operating lease liability, non-current	42,654	45,384
Lease obligations under finance leases, non-current	2,140	407
Derivative liability, non-current	2,253	5,162
Convertible debt	8,126	7,266
Deferred income tax liability	16,760	17,175
Contingent consideration payable, non-current	2,109
Liability on uncertain tax position and other long term liabilities	110,673	81,751
Total non-current liabilities	356,641	218,778
Total liabilities	434,098	425,778
Commitments and contingencies
Share Capital
Common shares, no par value, unlimited shares authorized; 291,507,430 and 288,327,497 shares outstanding as of June 30, 2024 and December 31, 2023, respectively	0	0
Additional paid in capital	945,797	944,859
Accumulated other comprehensive income	2,457	1,799
Accumulated deficit	(723,590)	(704,162)
Non-controlling interest	1,482	(1,756)
Total shareholders' equity	226,146	240,740
Total liabilities and shareholders' equity	660,244	666,518
Series A Convertible Preferred Stock
Share Capital
Preferred stock
Series B Convertible Preferred Stock
Share Capital
Preferred stock
Series C Convertible Preferred Stock
Share Capital
Preferred stock
Series D Convertible Preferred Stock
Share Capital
Preferred stock
Proportionate Voting Shares
Share Capital
Preferred stock
Exchangeable Shares
Share Capital
Preferred stock

Unaudited Interim Condensed C_2

Unaudited Interim Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Common stock, par value
Common stock, shares authorized, unlimited	Unlimited
Common stock, shares, outstanding	291,507,430	288,327,497
Series A Convertible Preferred Stock
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding	12,350	12,350
Series B Convertible Preferred Stock
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding	600	600
Series C Convertible Preferred Stock
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding
Series D Convertible Preferred Stock
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding
Proportionate Voting Shares
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding
Exchangeable Shares
Preferred stock, par value
Preferred stock, shares authorized, unlimited	Unlimited	Unlimited
Preferred stock, shares outstanding	63,492,038	63,492,038

Unaudited Interim Condensed C_3

Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Revenue, net	$ 77,523	$ 72,124	$ 158,156	$ 141,522
Cost of sales	39,840	35,898	81,742	71,396
Gross profit	37,683	36,226	76,414	70,126
Operating expenses:
General and administrative	24,060	30,476	52,068	58,206
Amortization and depreciation	2,190	2,242	4,405	4,271
Impairment of property and equipment and right of use assets			2,438	28
Other operating (income) expense	(1,186)	10	(1,186)	317
Total operating expenses	25,064	32,728	57,725	62,822
Income from operations	12,619	3,498	18,689	7,304
Other expense (income)
Loss from revaluation of contingent consideration	1,827		3,220
Gain on fair value of derivative liabilities and purchase option derivative assets	(2,922)	(215)	(1,939)	(653)
Finance and other expenses	8,891	8,171	17,480	18,258
Transaction and restructuring costs		389		392
Unrealized and realized foreign exchange loss (gain)	104	(101)	389	(132)
Unrealized and realized loss on investments	227	1,661	227	2,360
Income (loss) from continuing operations before provision for income taxes	4,492	(6,407)	(688)	(12,921)
Provision for income taxes	10,729	6,448	20,400	19,112
Net loss from continuing operations	(6,237)	(12,855)	(21,088)	(32,033)
Discontinued operations:
Loss from discontinued operations, net of tax		(621)		(4,212)
Net loss	(6,237)	(13,476)	(21,088)	(36,245)
Foreign currency translation adjustment	(260)	408	(658)	755
Comprehensive loss	(5,977)	(13,884)	(20,430)	(37,000)
Net loss from continuing operations attributable to:
Common and proportionate Shareholders of the Company	(8,180)	(14,998)	(25,235)	(36,362)
Non-controlling interests	1,943	2,143	4,147	4,329
Comprehensive loss attributable to:
Common and proportionate Shareholders of the Company	(7,920)	(16,027)	(24,577)	(41,329)
Non-controlling interests	$ 1,943	$ 2,143	$ 4,147	$ 4,329
Net loss per share - basic:
Continuing operations	$ (0.03)	$ (0.05)	$ (0.09)	$ (0.13)
Discontinued operations				(0.02)
Net loss per share - basic	$ (0.03)	$ (0.05)	$ (0.09)	$ (0.15)
Weighted average number of outstanding common shares	291,488,661	275,186,279	291,053,614	271,223,233
Net loss per share - diluted:
Continuing operations	$ (0.03)	$ (0.05)	$ (0.09)	$ (0.13)
Discontinued operations				(0.02)
Net loss per share - diluted	$ (0.03)	$ (0.05)	$ (0.09)	$ (0.15)
Weighted average number of outstanding common shares, assuming dilution	291,488,661	275,186,279	291,053,614	271,223,233

Unaudited Interim Condensed C_4

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Private placement	Common Stock	Common Stock Private placement	Exchangeable Shares	Preferred Stock Series A Convertible Preferred Stock	Preferred Stock Series B Convertible Preferred Stock	Common Shares Equivalent	Common Shares Equivalent Private placement	Additional Paid In Capital	Additional Paid In Capital Private placement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-Controlling Interest
Balance at Dec. 31, 2022	$ 321,171									$ 934,972		$ 2,085	$ (618,260)	$ 2,374
Balance, shares at Dec. 31, 2022			259,624,531		76,996,538	12,608	600	349,829,273
Shares issued - stock options, warrant and RSU exercises	81									81
Shares issued - stock options, warrant and RSU exercises, shares			392,846					392,846
Shares, options and warrants issued - acquisitions	743									743
Shares, options and warrants issued - acquisitions, shares			471,681					471,681
Shares, options and warrants issued - legal settlement	593									593
Shares, options and warrants issued - legal settlement, shares			402,185					402,185
Shares issued - conversion, shares			13,762,500		(13,504,500)	(258)
Share-based compensation expense	1,713									1,713
Options and warrants expired/forfeited										(1,698)			1,698
Capital distributions	(1,884)													(1,884)
Net loss for the period	(22,769)												(24,955)	2,186
Foreign currency translation adjustment	(347)											(347)
Balance at Mar. 31, 2023	299,301									936,404		1,738	(641,517)	2,676
Balance, shares at Mar. 31, 2023			274,653,743		63,492,038	12,350	600	351,095,985
Balance at Dec. 31, 2022	321,171									934,972		2,085	(618,260)	2,374
Balance, shares at Dec. 31, 2022			259,624,531		76,996,538	12,608	600	349,829,273
Net loss for the period	(36,245)
Balance at Jun. 30, 2023	295,599									945,926		1,330	(653,623)	1,966
Balance, shares at Jun. 30, 2023			286,807,780		63,492,038	12,350	600	363,250,022
Balance at Dec. 31, 2022	321,171									934,972		2,085	(618,260)	2,374
Balance, shares at Dec. 31, 2022			259,624,531		76,996,538	12,608	600	349,829,273
Balance at Dec. 31, 2023	240,740									944,859		1,799	(704,162)	(1,756)
Balance, shares at Dec. 31, 2023			288,327,497		63,492,038	12,350	600	364,769,739
Balance at Mar. 31, 2023	299,301									936,404		1,738	(641,517)	2,676
Balance, shares at Mar. 31, 2023			274,653,743		63,492,038	12,350	600	351,095,985
Shares issued - stock options, warrant and RSU exercises, shares			1,078					1,078
Shares, options and warrants issued - acquisitions	9,524									9,524
Shares, options and warrants issued - acquisitions, shares			5,442,282					5,442,282
Shares, options and warrants issued - legal settlement	201									201
Shares, options and warrants issued - legal settlement, shares			130,000					130,000
Share issued		$ 7,507									$ 7,507
Share issued, Shares				6,580,677					6,580,677
Share-based compensation expense	1,981									1,981
Options and warrants expired/forfeited										(3,514)			3,514
Capital distributions	(1,531)													(1,531)
Acquisition of non-controlling interest	(7,500)									(6,177)				(1,323)
Net loss for the period	(13,476)												(15,620)	2,144
Foreign currency translation adjustment	(408)											(408)
Balance at Jun. 30, 2023	295,599									945,926		1,330	(653,623)	1,966
Balance, shares at Jun. 30, 2023			286,807,780		63,492,038	12,350	600	363,250,022
Balance at Dec. 31, 2023	240,740									944,859		1,799	(704,162)	(1,756)
Balance, shares at Dec. 31, 2023			288,327,497		63,492,038	12,350	600	364,769,739
Shares issued - stock options, warrant and RSU exercises, shares			69,229					69,229
Share-based compensation expense	1,485									1,485
Options and warrants expired/forfeited										(3,819)			3,819
Capital distributions	(337)													(337)
Acquisition of non-controlling interest, Shares			2,888,088					2,888,088
Acquisition of non-controlling interest	4,674									3,300				1,374
Net loss for the period	(14,851)												(17,055)	2,204
Foreign currency translation adjustment	$ 398											398
Balance at Mar. 31, 2024										945,825		2,197	(717,398)	1,485
Balance, shares at Mar. 31, 2024	232,109		291,284,814		63,492,038	12,350	600	367,727,056
Balance at Dec. 31, 2023	$ 240,740									944,859		1,799	(704,162)	(1,756)
Balance, shares at Dec. 31, 2023			288,327,497		63,492,038	12,350	600	364,769,739
Net loss for the period	(21,088)
Balance at Jun. 30, 2024	$ 226,146									945,797		2,457	(723,590)	1,482
Balance, shares at Jun. 30, 2024			291,507,430		63,492,038	12,350	600	367,949,672
Balance at Mar. 31, 2024										945,825		2,197	(717,398)	1,485
Balance, shares at Mar. 31, 2024	232,109		291,284,814		63,492,038	12,350	600	367,727,056
Shares issued - stock options, warrant and RSU exercises, shares			222,616					222,616
Share-based compensation expense	$ 1,960									1,960
Options and warrants expired/forfeited										(1,988)			1,988
Capital distributions	(1,946)													(1,946)
Net loss for the period	(6,237)												(8,180)	1,943
Foreign currency translation adjustment	260											260
Balance at Jun. 30, 2024	$ 226,146									$ 945,797		$ 2,457	$ (723,590)	$ 1,482
Balance, shares at Jun. 30, 2024			291,507,430		63,492,038	12,350	600	367,949,672

Unaudited Interim Condensed C_5

Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities
Net loss from continuing operations	$ (21,088)	$ (32,033)
Adjustments to reconcile net loss to net cash provided by operating activities
Non-cash adjustments of inventory		1,081
Accretion expense	8,375	5,673
Depreciation of property and equipment and amortization of intangible assets	9,993	9,761
Amortization of operating right-of-use assets	1,481	932
Share-based compensation	3,446	3,694
Deferred income tax (recovery) expense	(415)	815
Gain on fair value of derivative liabilities and purchase option derivative assets	(1,939)	(653)
Gain on disposal of fixed assets	(17)	345
Unrealized and realized loss on investments	227	2,410
Loss from revaluation of contingent consideration	3,220
Impairment of property and equipment and right of use assets	2,438
Gain on lease termination	(1,169)
Bad debt recovery	(1,307)	(23)
Unrealized and realized foreign exchange loss (gain)	389	(132)
Changes in operating assets and liabilities
Receivables	1,358	318
Inventory	1,970	(7,851)
Prepaid expense and other current assets	119	(319)
Deposits	53	431
Other assets	77	714
Accounts payable and accrued liabilities and other payables	(8,019)	4,089
Operating lease liability	(1,147)	(337)
Other liability	(536)	(173)
Uncertain tax position liabilities	29,917	1,258
Corporate income tax payable	(1,591)	22,127
Deferred revenue	545	157
Net cash provided by operating activities- continuing operations	26,380	12,284
Net cash used in operating activities - discontinued operations		(3,164)
Net cash provided by operating activities	26,380	9,120
Investing activities
Investment in property and equipment	(4,272)	(4,504)
Investment in intangible assets	(699)	(262)
Principal payments received on lease receivable		104
Insurance recovery for property and equipment	871
Receipt of convertible debenture payment		738
Payment for land contracts	(478)	(769)
Cash portion of consideration paid in acquisitions, net of cash of acquired	(250)	(14,469)
Net cash used in investing activities - continuing operations	(4,828)	(19,162)
Net cash provided investing activities - discontinued operations		14,285
Net cash used in investing activities	(4,828)	(4,877)
Financing activities
Transfer of Employee Retention Credit		12,677
Proceeds from loan payable, net of transaction costs	3,137	23,872
Proceeds from options and warrants exercised		81
Loan principal paid	(18,048)	(40,359)
Loan amendment fee paid and prepayment premium paid		(1,178)
Capital distributions paid to non-controlling interests	(1,564)	(3,415)
Proceeds from private placement, net of share issuance costs		19,218
Payments made for financing obligations and finance lease	(316)	(941)
Net cash (used in) provided by financing activities- continuing operations	(16,791)	9,955
Net cash used in financing activities- discontinued operations		(5,539)
Net cash (used in) provided by financing activities	(16,791)	4,416
Net increase in cash and cash equivalents and restricted cash during the period	4,761	8,659
Net effects of foreign exchange	383	(901)
Cash and cash equivalents and restricted cash, beginning of the period	25,347	26,763
Cash and cash equivalents and restricted cash, end of the period	30,491	34,521
Supplemental disclosure with respect to cash flows
Income taxes paid (refund received)	(8,116)	(4,582)
Interest paid	12,599	9,259
Lease termination fee paid	271
Non-cash transactions
Equity and warrant liability issued for acquisitions and non-controlling interest	4,674	10,267
Shares issued for legal and liability settlement		794
Distribution Payable to Non-controlling Interests	719
Accrued capital purchases	$ 811	$ 529

Nature of Operations

Nature of Operations	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	1. Na ture of operations TerrAscend Corp. (the "Issuer") was incorporated under the Business Corporations Act (Ontario) on March 7, 2017 . The Issuer, through its subsidiaries, TerrAscend Growth Corp. (“TerrAscend”) and its subsidiaries (collectively, the Company”), is a leading North American cannabis company. TerrAscend has vertically integrated licensed operations in Pennsylvania, New Jersey, Michigan, Maryland and California. In addition, the Company has retail operations in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada. In the United States, TerrAscend’s cultivation and manufacturing provide product selection to both the medical and legal adult-use markets. Notwithstanding the fact that various states in the United States have implemented medical marijuana laws or have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970. The Company operates under one operating segment, which is the cultivation, production and sale of cannabis products. The Company owns a portfolio of operating businesses, including: • TerrAscend New Jersey (“TerrAscend NJ”), a majority owned operation with three dispensaries, and a cultivation/processing facility; • TerrAscend Maryland (“TerrAscend MD”), a wholly-owned operation with four dispensaries, and a cultivation/processing facility; • TerrAscend Pennsylvania (“TerrAscend PA”), a wholly-owned operation with six dispensaries, and a cultivation/processing facility; • TerrAscend Michigan (“TerrAscend MI”), a wholly-owned operation with twenty dispensaries, and three cultivation and processing facilities; • TerrAscend California (“TerrAscend CA”), a wholly-owned operation with four dispensaries, and a cultivation facility; and • TerrAscend Canada Inc. (“TerrAscend Canada”), a cannabis retailer in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada ("Cookies Canada"). The common shares in the capital of the Company ("Common Shares") commenced trading on the Canadian Securities Exchange ("CSE") on May 3, 2017 under the ticker symbol "TER" and continued trading on the CSE until the listing of the Common Shares on the Toronto Stock Exchange (the "TSX"). Effective July 4, 2023, the Common Shares commenced trading on the TSX under the ticker symbol "TSND". The Common Shares commenced trading on OTCQX on October 22, 2018 under the ticker symbol "TRSSF", which was subsequently changed to "TSNDF", effective July 6, 2023. The Company’s registered office is located at 77 City Centre Drive, Suite 501, Mississauga, Ontario, L5B 1M5, Canada .

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of significant accounting policies	2. Summary of significant accounting policies (a) Basis of presentation These unaudited interim condensed consolidated financial statements included herein (the “Consolidated Financial Statements”) of the Company and its subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The accompanying Consolidated Financial Statements contained in this report are unaudited. In the opinion of management, these Consolidated Financial Statements have been prepared on the same basis as the annual consolidated financial statements and notes thereto of the Company and include all adjustments, consisting only of normal recurring adjustments, considered necessary for the fair presentation of the Company’s financial position and operating results. The results for the three and six months ended June 30, 2024 are not necessarily indicative of the operating results for the year ended December 31, 2024, or any other interim or future periods. The accompanying Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and notes thereto of the Company for the year ended December 31, 2023 contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on March 14, 2024 (the "Annual Report"). There were no significant changes to the policies disclosed in Note 2 of the summary of significant accounting policies of the Company’s audited consolidated financial statements for the year ended December 31, 2023 in the Company's Annual Report. The accompanying Consolidated Financial Statements have been prepared on the going concern basis, under the historical cost convention, except for certain financial instruments that are measured at fair value as described herein. The Company previously concluded that substantial doubt existed as to its ability to continue as a going concern primarily due to the Company's current liabilities exceeding its current assets related to its loans maturing within the current year. On August 1, 2024, the Company entered into a four-year $ 140,000 senior secured term loan with an initial draw of $ 114,000 used to retire the majority of its loans coming due within the next year and a delayed draw of $ 26,000 , expected to occur on September 30, 2024 which will be used to retire the Chicago Atlantic Term Loan resulting in positive net working capital for the Company (see Note 25). Following the retiring and financing of the Company’s loans coming due within the next year, along with its ability to identify access to future capital, and continued improvement in cash flow from the Company's consolidated operations, management has determined that substantial doubt no longer exists in the Company's ability to continue as a going concern. Reclassification Certain prior year amounts have been reclassified to conform to the current year presentation. Specifically, (Gain) loss on disposal of fixed assets has been reclassified out of Impairment of property and equipment and right of use assets and into Other operating (income) expense on the Consolidated Statements of Operations and Comprehensive Loss.

Consolidation

Consolidation	6 Months Ended
	Jun. 30, 2024
Text Block [Abstract]
Consolidation	3. Consolidation The Company consolidates entities in which it has a controlling financial interest by evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). In connection with the listing of the Common Shares on the TSX, the Company reorganized its ownership structure to segregate the Company’s Canadian retail operations from TerrAscend's cultivation and manufacturing operations in the United States (the "Reorganization"). Following the completion of the Reorganization, the Company owns 95 % of its Canadian retail business. The Company continues to consolidate both its Canadian and U.S. cannabis operations under two different consolidation models. Subsequent to the Reorganization, all operations in the United States have a functional currency of the U.S. dollar ("USD"). Canadian operations continue to have a functional currency of the Canadian dollar ("CAD"). Voting Interest Entities A VOE is an entity in which (1) the total equity investment at risk is deemed sufficient to absorb the expected losses of the entity, (2) the at-risk equity holders, as a group, have all of the characteristics of a controlling financial interest and (3) the entity is structured with substantive voting rights. The Company consolidates the Canadian operations under a VOE model based on the controlling financial interest obtained through Common Shares with substantive voting rights. Variable Interest Entities A VIE is an entity that lacks one or more characteristics of a controlling financial interest defined under the voting interest model. The Company consolidates VIE when it has a variable interest that provide it with (1) the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). In connection with the Reorganization, TerrAscend issued and sold, on a private placement basis, Class A shares in the capital of TerrAscend ("Class A Shares") for aggregate gross proceeds of $ 1,000 to an investor ("Investment"). See Note 10 for accounting treatment of the Class A Shares. Following the closing of the Investment, the Class B shares ("Class B Shares") in the capital of TerrAscend held by the Company, representing all of the issued and outstanding Class B shares, were automatically exchanged for non-voting, non-participating exchangeable shares in the capital of TerrAscend ("Non-Voting Shares"), representing approximately 99.8 % of the issued and outstanding shares of TerrAscend on an as-converted basis. As a result of the limited rights associated with Non-Voting Shares that the Company holds following the closing of the Investment, the Company and TerrAscend entered into a protection agreement dated April 18, 2023 ("Protection Agreement"). The Protection Agreement provides for certain negative covenants in order to preserve the value of the Non-Voting Shares until such time as the Non-Voting Shares are converted into Class A Shares. The Issuer determined that TerrAscend is a VIE, as all of the Company’s U.S. activities continue to be conducted on behalf of the Company which has disproportionately few voting rights. After conducting an analysis of the following VIE factors; purpose and design of the VIE, the Protection Agreement in place, the structure of the Company's board of directors (the "Board"), and substantive kick-out rights of the holders of the Class A Shares, it was determined that the Company has the power to direct the activities of TerrAscend. In addition, given the structure of the Class A Shares where all of the losses and substantially all of the benefits of TerrAscend are absorbed by the Company, the Company consolidates as the primary beneficiary in accordance with Accounting Standards Codification ("ASC") 810, Consolidation . The Company's U.S. operations are consolidated through the VIE model. Therefore, substantially all of the Company's current assets, non-current assets, current liabilities and non-current liabilities are consolidated through the VIE model. The Company's assets and liabilities that are not consolidated through the VIE model include convertible debt, and derivative liability. The Company also consolidates a minimal amount of assets and liabilities within Canada. See Note 21 for more information .

Accounts Receivable, net

Accounts Receivable, net	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Accounts Receivable, net	4. Accounts receivable, net The Company's accounts receivable, net consisted of the following: June 30, 2024 December 31, 2023 Trade receivables $ 16,811 $ 28,403 Sales tax receivable 617 408 Other receivables 530 1,154 Provision for current expected credit losses ( 1,159 ) ( 10,917 ) Total receivables, net $ 16,799 $ 19,048 June 30, 2024 December 31, 2023 Trade receivables $ 16,811 $ 28,403 Less: provision for current expected credit losses ( 1,159 ) ( 10,917 ) Total trade receivables, net $ 15,652 $ 17,486 Of which Current 12,023 13,799 31-90 days 2,035 2,837 Over 90 days 2,753 11,767 Less: current expected credit losses ( 1,159 ) ( 10,917 ) Total trade receivables, net $ 15,652 $ 17,486 During the second quarter, the Company settled accounts receivable that had been previously accounted for as expected credit losses which resulted in a bad debt recovery of $ 4,188 within General and administrative expenses on the Consolidated Statements of Operations and Comprehensive Loss.

Acquisitions

Acquisitions	6 Months Ended
	Jun. 30, 2024
Asset Acquisition [Abstract]
Acquisitions	5. Acquisitions Contingent consideration The balances of the Company's contingent considerations are as follows: State Flower Apothecarium Peninsula Total Carrying amount, December 31, 2023 $ 1,406 $ 3,028 $ 2,012 $ 6,446 Settlement of contingent consideration ( 1,334 ) ( 3,591 ) — ( 4,925 ) Loss on revaluation of contingent consideration 705 1,895 620 3,220 Carrying amount, June 30, 2024 $ 777 $ 1,332 $ 2,632 $ 4,741 Less: current portion — — ( 2,632 ) ( 2,632 ) Non-current contingent consideration $ 777 $ 1,332 $ — $ 2,109 During the six months ended June 30, 2024, the Company amended the original purchase agreement and issued an aggregate of 2,888,088 Common Shares and paid $ 250 of cash to the sellers of its previously-acquired State Flower and The Apothecarium businesses. The issuance of Common Shares fully settled the previous contingent consideration balances. The Company provided a price protection on the Common Shares issued. The remaining balance recorded as at June 30, 2024 relates to the fair value of the price protection clause using the Black-Scholes Option Pricing Model ("Black-Scholes Model")

Inventory

Inventory	6 Months Ended
	Jun. 30, 2024
Inventory, Net [Abstract]
Inventory	6. Inventory The Company’s inventory of dry cannabis and cannabis derived products includes both purchased and internally produced inventory. The Company’s inventory is comprised of the following items: June 30, 2024 December 31, 2023 Raw materials $ 552 $ 378 Finished goods 19,636 18,821 Work in process 26,953 28,451 Accessories, supplies and consumables 3,868 4,033 Total inventory $ 51,009 $ 51,683

Discontinued operations

Discontinued operations	6 Months Ended
	Jun. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	7. Discontinued operations TerrAscend Canada operated out of a 67,300 square foot facility located in Mississauga, Ontario and was licensed to cultivate, process and sell cannabis for medical and adult-use purposes. These licenses allowed for sales of dried cannabis, cannabis oil and extracts, topicals, and edibles. The Company ceased operations at TerrAscend Canada’s manufacturing facility during the three months ended December 31, 2022. As such, TerrAscend Canada's Licensed Producer (as such term is defined in the Cannabis Act) results are presented in discontinued operations. The results of operations for the discontinued operations includes revenues and expenses directly attributable to the disposed of operations. Corporate and administrative expenses, including interest expense, not directly attributable to the operations were not allocated to the Canadian Licensed Producer business. The results of discontinued operations were as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Revenue, net $ — $ — $ — $ — Cost of Sales — — — — Gross profit — — — — Operating expenses: General and administrative — 455 — 756 Amortization and depreciation — - — 48 Impairment of property and equipment — — — 3,064 Total operating expenses — 455 — 3,868 Loss from discontinued operations — ( 455 ) — ( 3,868 ) Other expense Finance and other expenses — 166 — 344 Net loss from discontinued operations $ — $ ( 621 ) $ — $ ( 4,212 )

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	8. Property and equipment Property and equipment consisted of: June 30, 2024 December 31, 2023 Land $ 6,152 $ 6,103 Assets in process 19,130 24,211 Buildings & improvements 159,186 151,989 Machinery & equipment 36,146 35,370 Office furniture & equipment 9,185 9,066 Assets under finance leases 2,114 2,362 Total cost 231,913 229,101 Less: accumulated depreciation ( 38,573 ) ( 32,886 ) Property and equipment, net $ 193,340 $ 196,215 Assets in process primarily represent construction in progress related to both cultivation and dispensary facilities not yet completed, or otherwise not placed in service. During the six months ended June 30, 2024, the Company recorded an impairment loss of certain property and equipment of $ 2,438 due to the wind-down of one of its California dispensaries. As of June 30, 2024 and December 31, 2023 , borrowing costs were no t capitalized because the assets in process did not meet the criteria of a qualifying asset. Depreciation expense wa s $ 3,055 and $ 6,092 for the three and six months ended June 30, 2024 , respectively ($ 2,079 and $ 4,140 included in cost o f sales) and $ 3,395 and $ 6,652 for the three and six months ended June 30, 2023, respectively ($ 2,023 and $ 4,040 include d in cost of sales).

Intangible Assets and Goodwill

Intangible Assets and Goodwill	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	9. Intangible assets and goodwill Intangible assets consisted of the following: At June 30, 2024 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Finite lived intangible assets Software $ 2,529 $ ( 1,714 ) $ 815 Licenses 187,759 ( 23,031 ) 164,728 Non-compete agreements 280 ( 280 ) — Total finite lived intangible assets 190,568 ( 25,025 ) 165,543 Indefinite lived intangible assets Brand intangibles 46,972 — 46,972 Total indefinite lived intangible assets 46,972 — 46,972 Intangible assets, net $ 237,540 $ ( 25,025 ) $ 212,515 At December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Finite lived intangible assets Software $ 2,050 $ ( 720 ) $ 1,330 Licenses 186,624 ( 20,216 ) 166,408 Brand intangibles 1,144 ( 1,144 ) — Non-compete agreements 280 ( 280 ) — Total finite lived intangible assets 190,098 ( 22,360 ) 167,738 Indefinite lived intangible assets Brand intangibles 48,116 — 48,116 Total indefinite lived intangible assets 48,116 — 48,116 Intangible assets, net $ 238,214 $ ( 22,360 ) $ 215,854 Amortization expense was $ 1,941 and $ 3,872 for the three and six months ended June 30, 2024, respectively, ($ 724 and $ 1,448 included in cost of sales) and $ 1,595 and $ 3,109 for the three and six months ended June 30, 2023 ($ 725 and $ 1,450 included in cost of sales). Estimated future amortization expense for finite lived intangible assets for the next five years is as follow s: 2024 $ 3,684 2025 7,253 2026 7,242 2027 7,164 2028 7,112 Thereafter 133,088 Total $ 165,543 As of June 30, 2024, the weighted average amortization period remaining on intangible assets was 25.0 years. The Company's goodwill is allocated to one reportable segment. The following table summarizes the activity in the Company’s goodwill bala nce: Balance at December 31, 2023 $ 106,929 Additions at acquisition date - Impairment of goodwill - Balance at June 30, 2024 $ 106,929

Loans Payable

Loans Payable	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Loans Payable	10. Loans payable The Company's loans payable consisted of the following: June 30, 2024 December 31, 2023 Chicago Atlantic term loan due November 2024 (1) Principal amount $ 24,196 $ 24,611 Deferred financing cost — — Net carrying amount $ 24,196 $ 24,611 Ilera term loan due December 2024 (1) Principal amount $ 68,927 $ 76,927 Deferred financing cost ( 1,552 ) ( 3,191 ) Net carrying amount $ 67,375 $ 73,736 Stearns loan due December 2024 (1) Principal amount $ 24,638 $ 24,809 Deferred financing cost ( 426 ) ( 791 ) Net carrying amount $ 24,212 $ 24,018 Pelorus term loan due October 2027 Principal amount $ 45,478 $ 45,478 Deferred financing cost ( 1,334 ) ( 1,490 ) Net carrying amount $ 44,144 $ 43,988 Maryland Acquisition loans (2) Principal amount $ 19,115 $ 19,873 Unamortized discount ( 1,065 ) ( 1,403 ) Net carrying amount $ 18,050 $ 18,470 Other loans $ 3,651 $ 2,698 Short-term debt (1) $ 6,244 $ 11,849 Current portion of long-term debt 9,702 125,888 Loans payable, current $ 15,946 137,737 Loans payable, non-current $ 171,926 $ 61,633 Total loans payable $ 187,872 $ 199,370 (1) Subsequent to June 30, 2024, the Company retired four of its debt facilities and entered into a new loan agreement. The new debt is set to mature in August 2028 which resulted in a reclassification of $ 115,998 , net of deferred financing costs, between Loans payable, current and Loans payable, non-current. See note 25 for further details of the refinancing. (2) For maturity breakout, refer to Maryland Acquisition Loans section below. Total interest paid on all loan payables was $ 6,335 and $ 12,599 for the three and six months ended June 30, 2024, respectively, and $ 6,803 and $ 9,259 for the three and six months ended June 30, 2023, respectively. The Company had accrued interest on loans payable of $ 3,261 and $ 3,491 as of June 30, 2024 and December 31, 2023, respectively, included in accounts payable and accrued liabilities on the Consolidated Balance Sheets. Chicago Atlantic Term Loan In connection with the acquisition of Gage Growth on March 10, 2022 (the "Gage Acquisition"), the Company assumed a senior secured term loan that was amended to provide an amount of $ 25,000 (the “Chicago Atlantic Term Loan”) bearing an interest rate equal to the greater of (i) the U.S. "prime rate" plus 6.00 %, and (ii) 13.0 % and matures on November 1, 2024 . The Chicago Atlantic Loan was secured by a first lien on all Gage Growth assets. As of June 30, 2024, there was an outstanding principal amount of $ 24,196 under the Chicago Atlantic Term Loan. Subsequent to June 30, 2024, the Company made a prepayment of the Chicago Atlantic Term Loan of $ 1,500 at par. On August 1, 2024, the Company entered into a four-year $ 140,000 senior secured term loan that matures in August 2028, of which, a portion of the proceeds will be used to retire the Chicago Atlantic Term Loan and pay the outstanding principal amount of $ 22,696 (see Note 25). Ilera Term Loan On December 18, 2020, WDB Holding PA, a subsidiary of TerrAscend, entered into a senior secured term loan with a syndicate of lenders in the amount of $ 120,000 ("Ilera Term Loan"). The Ilera Term Loan is solely secured by the Company’s Pennsylvania-based Ilera Healthcare LLC (“Ilera”). The Ilera Term Loan bears interest at 12.875 % matures on December 17, 2024 . On January 2, 2024, the Company completed a prepayment of the Ilera Term Loan of $ 4,800 at the prepayment price of 100 % to par. On April 30, 2024, the Company made a prepayment of $ 3,200 of the Ilera Term Loan, at the prepayment price of 100 % to par. In accordance with ASC 470, Debt , these amendments were not considered extinguishment of debt. As of June 30, 2024, there was an outstanding principal amount of $ 68,927 under the Ilera Term Loan. Subsequent to June 30, 2024, the Company entered into a four-year $ 140,000 senior secured term loan that matures in August 2028, of which, a portion of the proceeds were used to retire the Ilera Term Loan and pay the outstanding principal amount of $ 68,927 (see Note 25). Stearns Loan On June 26, 2023, the Company closed on a $ 25,000 commercial loan with Stearns Bank, secured by the Company's cultivation facility in Pennsylvania and its Allegany Medical Marijuana Dispensary ("AMMD") dispensary in Cumberland, Maryland ("Stearns Loan"). The Stearns Loan bears an interest rate of prime plus 2.25 % and matures on December 26, 2024 . As of June 30, 2024, there was an outstanding principal amount of $ 24,638 under the Stearns Loan. Subsequent to June 30, 2024, the Company entered into a four-year $ 140,000 senior secured term loan that matures in August 2028, of which, a portion of the proceeds were used to retire the Stearns Loan and pay the outstanding principal amount of $ 24,638 (see Note 25). Pelorus Term Loan On October 11, 2022, subsidiaries of, TerrAscend, among others, entered into a loan agreement with Pelorus Fund REIT, LLC ("Pelorus") for a single-draw senior secured term loan (the “Pelorus Term Loan") in an aggregate principal amount of $ 45,478 . The Pelorus Term Loan is based on a variable rate tied to the one month Secured Overnight Financing Rate ("SOFR"), subject to a base rate, plus 9.5 %, with interest-only payments for the first 36 months and matures on October 11, 2027 . The base rate is defined as, on any day, the greatest of: (i) 2.5 %, (b) the effective federal funds rate in effect on such day plus 0.5 %, and (c) one month Secured Overnight Financing Rate ("SOFR") in effect on such day. The obligations of the borrowers under the Pelorus Term Loan are guaranteed by the Company, TerrAscend USA and certain other subsidiaries of TerrAscend and are secured by all of the assets of TerrAscend's Maryland and New Jersey businesses, including certain real estate in Maryland and New Jersey, but excludes all MD dispensaries. As of June 30, 2024, there was an outstanding principal amount of $ 45,478 under the Pelorus Term Loan. Maryland Acquisition Loans In connection with the acquisition of Derby 1, LLC ("Peninsula"), Hempaid, LLC ("Blue Ridge"), and Herbiculture Inc. ("Herbiculture"), (collectively, the "Maryland Acquisitions"), the Company entered into promissory notes with an aggregate principal amount of $ 20,625 that bear interest at rates ranging from 7.0 % to 10.5 % with maturities ranging from June 28, 2025 to June 30, 2027 . As of June 30, 2024, there was an outstanding principal amount of $ 19,115 under the Maryland Acquisition Loans. Other loans Stadium Ventures In connection with the Gage Acquisition, the Company assumed existing indebtedness in the form of a promissory note in the amount of $ 4,065 , which matures on December 31, 2024 . The promissory note bears interest at a rate of 6 %. As of June 30, 2024, there was an outstanding principal amount of $ 936 under the Stadium Ventures loan. Class A Shares of TerrAscend Growth In connection with the Reorganization (see Note 3), TerrAscend issued $ 1,000 of Class A shares with a 20 % guaranteed annual dividend to an investor (the “Investor”) pursuant to the terms of a subscription agreement between TerrAscend and the Investor dated April 20, 2023 (the “Subscription Agreement”). Pursuant to the terms of the Subscription Agreement, TerrAscend holds a call right to repurchase all of the Class A Shares issued to the Investor for an amount equal to the sum of: (a) the Repurchase/Put Price (as defined in the Subscription Agreement); plus (b) the amount equal to 40 % of the subscription amount less the aggregate dividends paid to the Investor as of the date of the exercise of the option. In addition, the Investor holds a put right that is exercisable at any time after four months’ advanced written notice following the five-year anniversary of the closing of the investment to put all (and only all) of the Class A Shares owned by the Investor to TerrAscend at the Repurchase/Put Price, payable in cash or shares. The instrument is considered as a debt for accounting purposes due to the economic characteristics and risks Short-Term Debt The average dollar amount of short-term debt for the six months ended June 30, 2024 was $ 8,727 with a weighted-average interest rate of 11.06 % as of June 30, 2024. On January 15, 2024, the Company paid off the IHC Real Estate LP promissory note with a payment of $ 5,000 . Subsequent to June 30, 2024, the Company entered into a four-year $ 140,000 senior secured term loan that matures in August 2028, of which, a portion of the proceeds were used to retire certain short-term debt and pay the outstanding principal amount of $ 1,715 (see Note 25). Maturities of loans payable Stated maturities of loans payable over the next five years are as follows: June 30, 2024 2024 $ 9,449 2025 7,942 2026 10,771 2027 44,483 2028 118,980 Thereafter — Total principal payments $ 191,625

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	11. Leases The majority of the Company’s leases are operating leases used primarily for corporate offices, retail, cultivation and manufacturing. The operating lease periods generally range from 1 to 25 years. The Company h ad two fi nance leases at June 30, 2024 and December 31, 2023. Amounts recognized in the consolidated balance sheet were as follows: June 30, 2024 December 31, 2023 Operating leases: Operating lease right-of-use assets $ 41,645 $ 43,440 Operating lease liability classified as current 2,330 1,244 Operating lease liability classified as non-current 42,654 45,384 Total operating lease liabilities $ 44,984 $ 46,628 Finance leases: Property and equipment, net $ 1,792 $ 2,112 Lease obligations under finance leases classified as current 93 2,030 Lease obligations under finance leases classified as non-current 2,140 407 Total finance lease obligations $ 2,233 $ 2,437 The Company recognized operating lease expense of $ 2,204 and $ 4,024 for the three and six months ended June 30, 2024, respectively, and $ 1,254 and $ 2,451 for the three and six months ended June 30, 2023, respectively. Other information related to operating leases at June 30, 2024 and December 31, 2023 consisted of the following: June 30, 2024 December 31, 2023 Weighted-average remaining lease term (years) Operating leases 12.3 12.5 Finance leases 1.8 1.2 Weighted-average discount rate Operating leases 11.42 % 11.43 % Finance leases 9.47 % 9.47 % Supplemental cash flow information related to leases are as follows: June 30, 2024 December 31, 2023 Cash paid for amounts included in measurement of operating lease liabilities $ 3,720 $ 6,264 Right-of-use assets obtained in exchange for operating lease obligations 509 16,603 Cash paid for amounts included in measurement of finance lease liabilities 65 153 Undiscounted lease obligations are as follows: Operating Finance Total 2024 $ 3,597 $ 65 $ 3,662 2025 7,278 2,132 9,410 2026 7,051 134 7,185 2027 6,933 136 7,069 2028 6,730 80 6,810 Thereafter 55,773 — 55,773 Total lease payments 87,362 2,547 89,909 Less: interest ( 42,378 ) ( 314 ) ( 42,692 ) Total lease liabilities $ 44,984 $ 2,233 $ 47,217

Convertible Debt

Convertible Debt	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Convertible Debt	12. Convertible Debt The Company's convertible debt consisted of the following: June 30, 2024 December 31, 2023 Convertible debt proceeds, net of transaction costs - Maturing June 2026 $ 10,098 $ 10,098 Allocation to conversion option 3,600 3,600 Allocation to debt 6,498 6,498 Interest and accretion 1,628 768 Net carrying amount $ 8,126 $ 7,266 The Company had $ 778 of accrued interest on convertible debt as of June 30, 2024 and no accrued interest on convertible debt as of December 31, 2023, included in accounts payable and accrued liabilities on the Consolidated Balance Sheets.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Shareholders' Equity	13. Shareholders' equity Warrants The following is a summary of the outstanding warrants for Common Shares: Number of Common Share Warrants Outstanding Number of Common Share Warrants Exercisable Weighted Average Exercise Price $ Weighted Average Remaining Life (years) Outstanding, December 31, 2023 23,330,542 818,927 $ 4.56 8.74 Granted 344,140 344,140 2.17 3.01 Expired — — — — Outstanding, June 30, 2024 23,674,682 1,163,067 $ 4.37 8.17 The weighted-average exercise price in the above table is denominated in a currency that is different from the functional currency of the Company and can influence the USD conversion. The following is a summary of the outstanding warrant liabilities that are exchangeable into Common Shares: Number of Common Share Warrants Outstanding Number of Common Share Warrants Exercisable Weighted Average Exercise Price $ Weighted Average Remaining Life (years) Outstanding, December 31, 2023 3,590,334 — $ 1.95 1.48 Granted — — — — Expired — — — — Outstanding, June 30, 2024 3,590,334 — $ 1.95 0.98

Share-based Compensation Plans

Share-based Compensation Plans	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Compensation Plans	14. Share-based compensation plans Share-based payments expense Total share-based payments expense was as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Stock options $ 1,183 $ 1,437 $ 2,087 $ 2,697 Restricted share units 777 544 1,358 997 Total share-based payments $ 1,960 $ 1,981 $ 3,445 $ 3,694 Stock Options The following table s ummarizes the stock option activity for the six months ended June 30, 2024: Number of Stock Options Weighted average remaining contractual life (in years) Weighted Average Exercise Price (per share) $ Aggregate intrinsic value Outstanding, December 31, 2023 16,278,380 4.74 $ 3.35 $ 658 Granted 1,845,000 — 2.82 — Exercised ( 25,000 ) — 1.60 — Forfeited ( 420,354 ) — 2.35 — Expired ( 1,707,057 ) — 3.48 — Outstanding, June 30, 2024 15,970,969 5.47 $ 3.36 $ 243 Exercisable, June 30, 2024 11,313,294 4.21 $ 3.63 $ 165 Nonvested, June 30, 2024 4,657,675 8.52 $ 2.68 $ 78 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between Company’s closing stock price on June 30, 2024 and December 31, 2023, respectively, and the exercise price, multiplied by the number of the in-the-money options) that would have been received by the option holders had they exercised their in-the-money options on June 30, 2024 and December 31, 2023, respectively. The total pre-tax intrinsic value (the difference between the market price of the Common Shares on the exercise date and the price paid by the option holder to exercise the option) related to stock options exercised is presented below: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Exercised $ 5 $ — $ 5 $ 551 The fair value of the various stock options granted were estimated using the Black-Scholes Model with the following assumptions: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. 1.91 - 2.89 1.71 - 2.81 Volatility 77.70 % - 78.31 % 77.79 % - 80.16 % Risk-free interest rate 3.18 % - 3.76 % 2.85 % - 4.26 % Expected life (years) 4.01 - 10.01 9.78 - 10.01 Dividend yield 0.00 % 0.00 % Forfeiture rate 26.11 % 26.11 % Volatility was estimated by using the historical volatility of the Company's stock price. The expected life in years represents the period of time that the options issued are expected to be outstanding. The risk-free rate is based on U.S. treasury bond issues with a remaining term approximately equal to the expected life of the options. Dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay cash dividends in the foreseeable future. The total estimated fair value of stock options that vested during the six months ended June 30, 2024 and 2023 was $ 4,594 and $ 5,563 , respectively. As of June 30, 2024, there was $ 7,658 of total unrecognized compensation cost related to unvested options. Restricted Share Units The following table summarizes the activities for the RSUs for th e six months ended June 30, 2024: Number of RSUs Outstanding, December 31, 2023 1,078,584 Granted 2,234,612 Vested ( 336,037 ) Forfeited ( 162,090 ) Outstanding, June 30, 2024 2,815,069 As of June 30, 2024, there was $ 4,194 of total unrecognized com pensation cost related to unvested RSUs.

Noncontrolling Interest

Noncontrolling Interest	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest [Abstract]
Non-controlling Interest	15. Non-controlling interest Non-controlling interest consists mainly of a 12.5 % minority ownership interest in TerrAscend's New Jersey operations. On January 19, 2024, the Company reduced its non-controlling interest through the acquisition of the remaining 50.1 % equity in both State Flower and three Apothecarium dispensaries in California. The carrying amount of non-controlling interest was adjusted by $ 1,374 and recognized in additional paid in capital and attributed to the parent's equity holders. The following table s ummarizes the non-controlling interest activity for the six months ended June 30, 2024: June 30, 2024 December 31, 2023 Opening carrying amount $ ( 1,756 ) $ 2,374 Capital distributions ( 2,283 ) ( 11,622 ) Acquisition of non-controlling interest 1,374 ( 1,323 ) Net income attributable to non-controlling interest 4,147 8,815 Ending carrying amount $ 1,482 $ ( 1,756 )

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Parties	16. Related parties Parties are related if one party has the ability to control or exercise significant influence over the other party in making financing and operating decisions. At June 30, 2024, amounts due to/from related parties consisted of: (a) Loans payable : During the year ended December 31, 2020, a small number of related persons, which consisted of key management of the Company, participated in the Ilera term loan (Note 10), which makes up $ 142 and $ 159 of the total loan principal balance at June 30, 2024 and December 31, 2023 , respectively.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	17. Income taxes The Company's effective tax rate was 239% and (2,965)% for the three and six months ended June 30, 2024 and ( 101 )% and ( 148 )% for the three and six months ended June 30, 2023. The Company has computed its provision for income taxes based on the actual effective tax rate for the quarter as the Company believes this is the best estimate for the annual effective tax rate. The Company is subject to income taxes in the United States and Canada. Significant judgment is required in evaluating the Company’s uncertain tax positions and determining the provision for income taxes. The Company recognizes benefits from uncertain tax positions based on the cumulative probability method whereby the largest benefit with a cumulative probability of greater than 50% is recorded. An uncertain tax position is not recognized if it has less than a 50% likelihood of being sustained. A reconciliation of the beginning and ending amount of unrecognized tax benefits for the period presented: For the Six Months Ended June 30, 2024 Balance, beginning of period $ 84,485 Increases based on tax positions related to prior years 32,976 Additions based on tax positions related to the current year 17,248 Expirations of applicable statutes of limitations - Settlements with tax authorities - Ending carrying amount $ 134,709 A reconciliation of the beginning and ending amount of uncertain tax liabilities, inclusive of accruals for related penalties and interest, for the period presented: For the Six Months Ended June 30, 2024 Balance, beginning of period $ 77,084 Increases based on tax positions related to prior years 6,899 Additions based on tax positions related to the current year 16,081 Additions based on refunds received related to prior years 8,371 Reclass of tax payments on deposit 1,108 Ending carrying amount $ 109,543 The Company had an unrecognized tax benefits of $ 134,709 and $ 84,485 as of June 30, 2024 and December 31, 2023, respectively. The increase in uncertain tax positions is primarily due to legal interpretations that challenge the Company's tax liability under the Code (“280E Tax Position”). The Company believes that it is reasonably possible that the unrecognized tax benefits will increase over the next 12 months due to its 280E Tax Position. Of the unrecognized tax benefits amounts, $ 12,772 and $ 10,459 as of June 30, 2024 and December 31, 2023, respectively, is unrelated to its 280E Tax Position. The unrecognized tax liabilities are combined with other long term liabilities of $ 1,130 and $ 4,667 as at June 30, 2024 and December 31, 2023, respectively, on the consolidated balance sh eets. Related to its 280E Tax Position, the Company has filed the majority of its amended federal and state returns for tax years 2020 through 2022. During the period ended June 30, 2024, the Company received refunds related primarily to the amended federal tax return for tax year 2020 in the amount of $ 8,371 , including interest .

General and Administrative Expe

General and Administrative Expenses	6 Months Ended
	Jun. 30, 2024
General and Administrative Expense [Abstract]
General and administrative expenses	18. General and administrative expenses The Company’s general and administrative expenses were as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Office and general $ 3,662 $ 3,733 $ 7,551 7,828 Professional fees 3,840 5,103 6,901 8,476 Lease expense 2,204 1,294 4,024 2,538 Facility and maintenance 1,034 1,364 2,359 2,608 Salaries and wages 14,974 14,334 29,870 27,830 Share-based compensation 1,960 1,981 3,445 3,694 Sales and marketing 1,493 2,599 2,958 5,255 Bad debt (recovery) expense ( 4,236 ) 68 ( 4,169 ) ( 23 ) Insurance recovery for property and equipment ( 871 ) — ( 871 ) — Total $ 24,060 $ 30,476 $ 52,068 $ 58,206

Revenue, Net

Revenue, Net	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue, Net	19. Revenue, net The Company’s disaggregated net revenue by source, primarily due to the Company’s contracts with its external customers was as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Retail $ 53,240 $ 58,254 $ 107,098 $ 113,676 Wholesale 24,283 13,870 51,058 27,846 Total $ 77,523 $ 72,124 $ 158,156 $ 141,522 For the three and six months ended June 30, 2024 and 2023 , the Company did no t have any single customer that accounted for 10% or more of the Company’s revenue.

Finance and Other Expenses

Finance and Other Expenses	6 Months Ended
	Jun. 30, 2024
Finance And Other Expenses [Abstract]
Finance and Other Expenses	20. Finance and other expenses The Company’s finance and other exp enses included the following: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Interest and accretion $ 9,132 $ 7,965 $ 18,004 $ 15,840 Employee retention credits and transfer fee — — — 2,235 Other income ( 241 ) 206 ( 524 ) 183 Total $ 8,891 $ 8,171 $ 17,480 $ 18,258

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Segment Information	21. Segment information Operating Segment The Company determines its operating segments according to how the business activities are managed and evaluated by the Company’s chief operating decision maker. The Company operates under one operating segment, being the cultivation, production and sale of cannabis products. Geography The Company has subsidiaries located in Canada and the United States. For the three months ended June 30, 2024, net revenue was primarily generated from sales in the United States. As a result of the Reorganization (Note 3), the Company consolidated its retail location in Canada and generated net revenue of $ 274 and $ 538 the three and six months ended June 30, 2024, respectively. The Company had non-current assets by geography of: June 30, 2024 December 31, 2023 United States $ 554,839 $ 562,854 Canada 598 775 Total $ 555,437 $ 563,629

Capital Management

Capital Management	6 Months Ended
	Jun. 30, 2024
Capital Management [Abstract]
Capital Management	22. Capital management The Company’s objective in managing capital is to ensure a sufficient liquidity position to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders. In order to achieve this objective, the Company prepares a capital budget to manage its capital structure. The Company defines capital as borrowings, equity comprised of issued share capital, share-based payments and accumulated deficit, as well as funds borrowed from related parties. Since inception, the Company has primarily financed its liquidity needs through the issuance of share capital and debt. The equity issuances are outlined in Note 13, debt modifications are outlined in Note 10, and debt financings are outlined in Note 12. The Company is subject to financial covenants as a result of its loans payable with various lenders. The Company is in compliance with its debt covenants as of June 30, 2024 . In the event that, in future periods, the Company’s financial results are below levels required to maintain compliance with any of its covenants, the Company will assess and undertake appropriate corrective initiatives with a view to allowing it to continue to comply with its covenants. Other than these items related to loans payable, the Company is not subject to externally imposed capital requirements.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Financial Instruments and Risk Management	23. Financial instruments and risk management Assets and liabilities measured at fair value Cash and cash equivalents, net accounts receivable, accounts payable and accrued liabilities, loans payable, convertible debentures, and other current receivables and payables represent financial instruments for which the carrying amount approximates fair value due to their short-term maturities. The following table represents the fair value amounts of financial assets and financial liabilities measured at estimated fair value on a recurring basis: At June 30, 2024 At December 31, 2023 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 27,378 — — $ 22,241 — — Restricted cash 3,113 — — 3,106 — — Total Assets $ 30,491 — — $ 25,347 — $ — Liabilities Contingent consideration payable — 4,741 — — 2,012 4,434 Detachable warrants — 2,253 — — 3,332 — Bifurcated conversion options — 899 — — 1,830 — Total Liabilities $ — $ 7,893 $ — $ — $ 7,174 $ 4,434 There were no transfers between the levels of fair value hierarchy during the three and six months ended June 30, 2024. The valuation approaches and key inputs for each category of assets or liabilities that are classified within levels of the fair value hierarchy are presented below: Level 1 Cash, cash equivalents, and restricted cash, net accounts receivable, accounts payable and accrued liabilities, and other current receivables and payables represent financial instruments for which the carrying amount approximates fair value due to their short-term maturities. Level 2 The following table summarizes the changes in the derivative liability for t he six months ended June 30, 2024: Balance at December 31, 2023 $ 5,162 Fair value gain on revaluation of warrants and conversion option ( 1,939 ) Effects of movements in foreign exchange ( 71 ) Balance at June 30, 2024 $ 3,152 Warrant liability and conversion option The Company's warrant liability consists of a detachable warrant issued through the private placement (Note 13), and a conversion option related to the convertible debenture offering (Note 12). Detachable Warrants The detachable warrants issued as a part of the June 2023 private placement (Note 13) have been measured at fair value as of June 30, 2024. Key inputs and assumptions used in the Black-Scholes Model were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 1.95 $ 1.95 Annual volatility 74.9 % 74.7 % Annual risk-free rate 5.09 % 4.23 % Expected term (in years) 0.98 1.48 Bifurcated conversion options The conversion option issued as a part of the June and August 2023 private placement (Note 12) has been measured at fair value as of June 30, 2024. Key inputs and assumptions used in the Black-Scholes Model were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 2.01 $ 2.01 Annual volatility 77.0 % 70.1 % Annual risk-free rate 4.71 % 4.23 % Expected term (in years) 1.98 - 2.09 2.48 - 2.59 Contingent Consideration Payable The fair value of the Peninsula Contingent Consideration was calculated using the Black-Scholes Model. Key inputs and assumptions were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 1.65 $ 1.65 Annual volatility 83.1 % 63.3 % Annual risk-free rate 5.33 % 4.73 % Expected term (in years) 0.50 0.99 The fair value of the State Flower and The Apothecarium Contingent Considerations were calculated using the Black-Scholes Model. Key inputs and assumptions were as follows: June 30, 2024 January 19, 2024 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.95 Option exercise price $ 1.76 $ 1.76 Annual volatility 83.1 % 68.7 % Annual risk-free rate 5.33 % 5.21 % Expected term (in years) 1.56 2.00

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	24. Commitments and contingencies Legal proceedings In the ordinary course of business, the Company is involved in a number of lawsuits incidental to its business, including litigation related to intellectual property, employment, and commercial matters. Although it is difficult to predict the ultimate outcome of these matters, management believes that any ultimate liability would not have a material adverse effect on the Company’s Consolidated Balance Sheets or Consolidated Statements of Operations and Comprehensive Loss. At June 30, 2024, there were no pending lawsuits that could reasonably be expected to have a material effect on the results of the Company’s Consolidated Financial Statements, except for the proceedings described below. Pure X Litigation On August 9, 2023, AEY Capital LLC (“AEY”), a licensed subsidiary of TerrAscend, filed a lawsuit in Oakland County Circuit Court (the "Oakland Court") against Pure X, LLC (“Pure X”) seeking damages in the amount of $ 14,969 (the “AEY Claim”). The AEY Claim alleges breach of contract, quantum meruit/unjust enrichment, account stated and statutory conversion. AEY’s alleged damages were related to Pure X’s failure to pay for various cannabis products sold by AEY. This matter was settled between the parties and dismissed with prejudice by the Oakland Court on June 28, 2024 .

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	25. Subsequent events On July 19, 2024, the Company made a prepayment of the Chicago Atlantic Term Loan of $ 1,500 at par. On August 1, 2024, the Company and TerrAscend USA, Inc., as guarantors, and each of WDB Holding CA, Inc., WDB Holding PA, Inc., WDB Holding MI, Inc., Moose Curve Holdings, LLC, and Hempaid, LLC, including certain of each of their respective subsidiaries, as borrowers (collectively, the “Borrowers”), and FG Agency Lending LLC, as the Administrative Agent (the “Agent”) entered into a Loan Agreement (the “FG Loan”). The FG Loan provides for a four-year , $ 140,000 senior-secured term loan with an initial draw on August 1, 2024, upon closing of the FG Loan, of $ 114,000 (the “Initial Draw”) and a delayed draw of $ 26,000 expected to occur on September 30, 2024 (the “Delayed Draw”). Proceeds from the Initial Draw were used to retire the Ilera Term Loan, the Stearns Loan and certain other indebtedness (collectively, the “Retired Loans”), in addition to being used for working capital and general corporate purposes. As a result, each outstanding obligation under the Retired Loans were repaid in full and subsequently terminated. The proceeds from the Delayed Draw will be used to retire the Chicago Atlantic Term Loan. The FG Loan is guaranteed by the Company and TerrAscend USA, Inc. and is secured by substantially all of the assets of the Borrowers. The FG Loan bears interest at 12.75 % per annum and matures on August 1, 2028. Certain funds controlled by the Company’s Executive Chairman, Jason Wild, a related party of the Company, have invested approximately $ 7,500 under the FG Loan.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of presentation	These unaudited interim condensed consolidated financial statements included herein (the “Consolidated Financial Statements”) of the Company and its subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The accompanying Consolidated Financial Statements contained in this report are unaudited. In the opinion of management, these Consolidated Financial Statements have been prepared on the same basis as the annual consolidated financial statements and notes thereto of the Company and include all adjustments, consisting only of normal recurring adjustments, considered necessary for the fair presentation of the Company’s financial position and operating results. The results for the three and six months ended June 30, 2024 are not necessarily indicative of the operating results for the year ended December 31, 2024, or any other interim or future periods. The accompanying Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and notes thereto of the Company for the year ended December 31, 2023 contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission (the "SEC") on March 14, 2024 (the "Annual Report"). There were no significant changes to the policies disclosed in Note 2 of the summary of significant accounting policies of the Company’s audited consolidated financial statements for the year ended December 31, 2023 in the Company's Annual Report.
Reclassification	Reclassification Certain prior year amounts have been reclassified to conform to the current year presentation. Specifically, (Gain) loss on disposal of fixed assets has been reclassified out of Impairment of property and equipment and right of use assets and into Other operating (income) expense on the Consolidated Statements of Operations and Comprehensive Loss.

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Schedule of Accounts Receivable, net	The Company's accounts receivable, net consisted of the following: June 30, 2024 December 31, 2023 Trade receivables $ 16,811 $ 28,403 Sales tax receivable 617 408 Other receivables 530 1,154 Provision for current expected credit losses ( 1,159 ) ( 10,917 ) Total receivables, net $ 16,799 $ 19,048
Schedule of Trade Receivables	June 30, 2024 December 31, 2023 Trade receivables $ 16,811 $ 28,403 Less: provision for current expected credit losses ( 1,159 ) ( 10,917 ) Total trade receivables, net $ 15,652 $ 17,486 Of which Current 12,023 13,799 31-90 days 2,035 2,837 Over 90 days 2,753 11,767 Less: current expected credit losses ( 1,159 ) ( 10,917 ) Total trade receivables, net $ 15,652 $ 17,486

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Jun. 30, 2024
Business Acquisition [Line Items]
Schedule of Balances of Contingent Consideration	The balances of the Company's contingent considerations are as follows: State Flower Apothecarium Peninsula Total Carrying amount, December 31, 2023 $ 1,406 $ 3,028 $ 2,012 $ 6,446 Settlement of contingent consideration ( 1,334 ) ( 3,591 ) — ( 4,925 ) Loss on revaluation of contingent consideration 705 1,895 620 3,220 Carrying amount, June 30, 2024 $ 777 $ 1,332 $ 2,632 $ 4,741 Less: current portion — — ( 2,632 ) ( 2,632 ) Non-current contingent consideration $ 777 $ 1,332 $ — $ 2,109

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2024
Inventory, Net [Abstract]
Schedule of Inventory	The Company’s inventory of dry cannabis and cannabis derived products includes both purchased and internally produced inventory. The Company’s inventory is comprised of the following items: June 30, 2024 December 31, 2023 Raw materials $ 552 $ 378 Finished goods 19,636 18,821 Work in process 26,953 28,451 Accessories, supplies and consumables 3,868 4,033 Total inventory $ 51,009 $ 51,683

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Summary of Major Classes of Assets and Liabilities and Results from Discontinued Operations	The results of operations for the discontinued operations includes revenues and expenses directly attributable to the disposed of operations. Corporate and administrative expenses, including interest expense, not directly attributable to the operations were not allocated to the Canadian Licensed Producer business. The results of discontinued operations were as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Revenue, net $ — $ — $ — $ — Cost of Sales — — — — Gross profit — — — — Operating expenses: General and administrative — 455 — 756 Amortization and depreciation — - — 48 Impairment of property and equipment — — — 3,064 Total operating expenses — 455 — 3,868 Loss from discontinued operations — ( 455 ) — ( 3,868 ) Other expense Finance and other expenses — 166 — 344 Net loss from discontinued operations $ — $ ( 621 ) $ — $ ( 4,212 )

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Components of Property and Equipment	Property and equipment consisted of: June 30, 2024 December 31, 2023 Land $ 6,152 $ 6,103 Assets in process 19,130 24,211 Buildings & improvements 159,186 151,989 Machinery & equipment 36,146 35,370 Office furniture & equipment 9,185 9,066 Assets under finance leases 2,114 2,362 Total cost 231,913 229,101 Less: accumulated depreciation ( 38,573 ) ( 32,886 ) Property and equipment, net $ 193,340 $ 196,215

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consisted of the following: At June 30, 2024 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Finite lived intangible assets Software $ 2,529 $ ( 1,714 ) $ 815 Licenses 187,759 ( 23,031 ) 164,728 Non-compete agreements 280 ( 280 ) — Total finite lived intangible assets 190,568 ( 25,025 ) 165,543 Indefinite lived intangible assets Brand intangibles 46,972 — 46,972 Total indefinite lived intangible assets 46,972 — 46,972 Intangible assets, net $ 237,540 $ ( 25,025 ) $ 212,515 At December 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Finite lived intangible assets Software $ 2,050 $ ( 720 ) $ 1,330 Licenses 186,624 ( 20,216 ) 166,408 Brand intangibles 1,144 ( 1,144 ) — Non-compete agreements 280 ( 280 ) — Total finite lived intangible assets 190,098 ( 22,360 ) 167,738 Indefinite lived intangible assets Brand intangibles 48,116 — 48,116 Total indefinite lived intangible assets 48,116 — 48,116 Intangible assets, net $ 238,214 $ ( 22,360 ) $ 215,854
Schedule of Estimated Future Amortization Expense for Finite Lived Intangible Assets	Estimated future amortization expense for finite lived intangible assets for the next five years is as follow s: 2024 $ 3,684 2025 7,253 2026 7,242 2027 7,164 2028 7,112 Thereafter 133,088 Total $ 165,543
Activity in Goodwill Balance	The following table summarizes the activity in the Company’s goodwill bala nce: Balance at December 31, 2023 $ 106,929 Additions at acquisition date - Impairment of goodwill - Balance at June 30, 2024 $ 106,929

Loans Payable (Tables)

Loans Payable (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Loans Payable	The Company's loans payable consisted of the following: June 30, 2024 December 31, 2023 Chicago Atlantic term loan due November 2024 (1) Principal amount $ 24,196 $ 24,611 Deferred financing cost — — Net carrying amount $ 24,196 $ 24,611 Ilera term loan due December 2024 (1) Principal amount $ 68,927 $ 76,927 Deferred financing cost ( 1,552 ) ( 3,191 ) Net carrying amount $ 67,375 $ 73,736 Stearns loan due December 2024 (1) Principal amount $ 24,638 $ 24,809 Deferred financing cost ( 426 ) ( 791 ) Net carrying amount $ 24,212 $ 24,018 Pelorus term loan due October 2027 Principal amount $ 45,478 $ 45,478 Deferred financing cost ( 1,334 ) ( 1,490 ) Net carrying amount $ 44,144 $ 43,988 Maryland Acquisition loans (2) Principal amount $ 19,115 $ 19,873 Unamortized discount ( 1,065 ) ( 1,403 ) Net carrying amount $ 18,050 $ 18,470 Other loans $ 3,651 $ 2,698 Short-term debt (1) $ 6,244 $ 11,849 Current portion of long-term debt 9,702 125,888 Loans payable, current $ 15,946 137,737 Loans payable, non-current $ 171,926 $ 61,633 Total loans payable $ 187,872 $ 199,370 (1) Subsequent to June 30, 2024, the Company retired four of its debt facilities and entered into a new loan agreement. The new debt is set to mature in August 2028 which resulted in a reclassification of $ 115,998 , net of deferred financing costs, between Loans payable, current and Loans payable, non-current. See note 25 for further details of the refinancing. (2) For maturity breakout, refer to Maryland Acquisition Loans section below.
Summary of Stated maturities of Loans Payable	Stated maturities of loans payable over the next five years are as follows: June 30, 2024 2024 $ 9,449 2025 7,942 2026 10,771 2027 44,483 2028 118,980 Thereafter — Total principal payments $ 191,625

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Summary of Amounts Recognized in Consolidated Balance Sheet	Amounts recognized in the consolidated balance sheet were as follows: June 30, 2024 December 31, 2023 Operating leases: Operating lease right-of-use assets $ 41,645 $ 43,440 Operating lease liability classified as current 2,330 1,244 Operating lease liability classified as non-current 42,654 45,384 Total operating lease liabilities $ 44,984 $ 46,628 Finance leases: Property and equipment, net $ 1,792 $ 2,112 Lease obligations under finance leases classified as current 93 2,030 Lease obligations under finance leases classified as non-current 2,140 407 Total finance lease obligations $ 2,233 $ 2,437
Summary of Other Information related to Operating Leases	Other information related to operating leases at June 30, 2024 and December 31, 2023 consisted of the following: June 30, 2024 December 31, 2023 Weighted-average remaining lease term (years) Operating leases 12.3 12.5 Finance leases 1.8 1.2 Weighted-average discount rate Operating leases 11.42 % 11.43 % Finance leases 9.47 % 9.47 %
Summary of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases are as follows: June 30, 2024 December 31, 2023 Cash paid for amounts included in measurement of operating lease liabilities $ 3,720 $ 6,264 Right-of-use assets obtained in exchange for operating lease obligations 509 16,603 Cash paid for amounts included in measurement of finance lease liabilities 65 153
Summary of Undiscounted Lease Obligations	Undiscounted lease obligations are as follows: Operating Finance Total 2024 $ 3,597 $ 65 $ 3,662 2025 7,278 2,132 9,410 2026 7,051 134 7,185 2027 6,933 136 7,069 2028 6,730 80 6,810 Thereafter 55,773 — 55,773 Total lease payments 87,362 2,547 89,909 Less: interest ( 42,378 ) ( 314 ) ( 42,692 ) Total lease liabilities $ 44,984 $ 2,233 $ 47,217

Convertible Debt (Tables)

Convertible Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Summary Of Convertible Debt	The Company's convertible debt consisted of the following: June 30, 2024 December 31, 2023 Convertible debt proceeds, net of transaction costs - Maturing June 2026 $ 10,098 $ 10,098 Allocation to conversion option 3,600 3,600 Allocation to debt 6,498 6,498 Interest and accretion 1,628 768 Net carrying amount $ 8,126 $ 7,266

Shareholders' Equity (Tables)

Shareholders' Equity (Tables) - Common Stock	6 Months Ended
	Jun. 30, 2024
Class Of Stock [Line Items]
Summary of Outstanding Warrants	The following is a summary of the outstanding warrants for Common Shares: Number of Common Share Warrants Outstanding Number of Common Share Warrants Exercisable Weighted Average Exercise Price $ Weighted Average Remaining Life (years) Outstanding, December 31, 2023 23,330,542 818,927 $ 4.56 8.74 Granted 344,140 344,140 2.17 3.01 Expired — — — — Outstanding, June 30, 2024 23,674,682 1,163,067 $ 4.37 8.17
Gage Growth Corp
Class Of Stock [Line Items]
Summary of Outstanding Warrants	The following is a summary of the outstanding warrant liabilities that are exchangeable into Common Shares: Number of Common Share Warrants Outstanding Number of Common Share Warrants Exercisable Weighted Average Exercise Price $ Weighted Average Remaining Life (years) Outstanding, December 31, 2023 3,590,334 — $ 1.95 1.48 Granted — — — — Expired — — — — Outstanding, June 30, 2024 3,590,334 — $ 1.95 0.98

Share-based Compensation Plans

Share-based Compensation Plans (Tables)	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Total Share-Based Payments Expense	Total share-based payments expense was as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Stock options $ 1,183 $ 1,437 $ 2,087 $ 2,697 Restricted share units 777 544 1,358 997 Total share-based payments $ 1,960 $ 1,981 $ 3,445 $ 3,694
Summary of Stock Option Activity	The following table s ummarizes the stock option activity for the six months ended June 30, 2024: Number of Stock Options Weighted average remaining contractual life (in years) Weighted Average Exercise Price (per share) $ Aggregate intrinsic value Outstanding, December 31, 2023 16,278,380 4.74 $ 3.35 $ 658 Granted 1,845,000 — 2.82 — Exercised ( 25,000 ) — 1.60 — Forfeited ( 420,354 ) — 2.35 — Expired ( 1,707,057 ) — 3.48 — Outstanding, June 30, 2024 15,970,969 5.47 $ 3.36 $ 243 Exercisable, June 30, 2024 11,313,294 4.21 $ 3.63 $ 165 Nonvested, June 30, 2024 4,657,675 8.52 $ 2.68 $ 78 The total pre-tax intrinsic value (the difference between the market price of the Common Shares on the exercise date and the price paid by the option holder to exercise the option) related to stock options exercised is presented below: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Exercised $ 5 $ — $ 5 $ 551
Summary of Weighted-average Assumptions used to Estimate Fair Value of Various Stock Options	The fair value of the various stock options granted were estimated using the Black-Scholes Model with the following assumptions: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. 1.91 - 2.89 1.71 - 2.81 Volatility 77.70 % - 78.31 % 77.79 % - 80.16 % Risk-free interest rate 3.18 % - 3.76 % 2.85 % - 4.26 % Expected life (years) 4.01 - 10.01 9.78 - 10.01 Dividend yield 0.00 % 0.00 % Forfeiture rate 26.11 % 26.11 %
Summary of Activities for Unvested RSUs	The following table summarizes the activities for the RSUs for th e six months ended June 30, 2024: Number of RSUs Outstanding, December 31, 2023 1,078,584 Granted 2,234,612 Vested ( 336,037 ) Forfeited ( 162,090 ) Outstanding, June 30, 2024 2,815,069

Noncontrolling Interest (Tables

Noncontrolling Interest (Tables)	6 Months Ended
	Jun. 30, 2024
Noncontrolling Interest [Abstract]
Schedule of Ownership in Minority Interest	The following table s ummarizes the non-controlling interest activity for the six months ended June 30, 2024: June 30, 2024 December 31, 2023 Opening carrying amount $ ( 1,756 ) $ 2,374 Capital distributions ( 2,283 ) ( 11,622 ) Acquisition of non-controlling interest 1,374 ( 1,323 ) Net income attributable to non-controlling interest 4,147 8,815 Ending carrying amount $ 1,482 $ ( 1,756 )

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of Reconciliation of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits for the period presented: For the Six Months Ended June 30, 2024 Balance, beginning of period $ 84,485 Increases based on tax positions related to prior years 32,976 Additions based on tax positions related to the current year 17,248 Expirations of applicable statutes of limitations - Settlements with tax authorities - Ending carrying amount $ 134,709
Schedule of Reconciliation of Uncertain Tax Liabilities, Inclusive of Accruals for Related Penalties and Interest	A reconciliation of the beginning and ending amount of uncertain tax liabilities, inclusive of accruals for related penalties and interest, for the period presented: For the Six Months Ended June 30, 2024 Balance, beginning of period $ 77,084 Increases based on tax positions related to prior years 6,899 Additions based on tax positions related to the current year 16,081 Additions based on refunds received related to prior years 8,371 Reclass of tax payments on deposit 1,108 Ending carrying amount $ 109,543

General and Administrative Ex_2

General and Administrative Expenses (Tables)	6 Months Ended
	Jun. 30, 2024
General and Administrative Expense [Abstract]
Summary of General and Administrative Expenses	The Company’s general and administrative expenses were as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Office and general $ 3,662 $ 3,733 $ 7,551 7,828 Professional fees 3,840 5,103 6,901 8,476 Lease expense 2,204 1,294 4,024 2,538 Facility and maintenance 1,034 1,364 2,359 2,608 Salaries and wages 14,974 14,334 29,870 27,830 Share-based compensation 1,960 1,981 3,445 3,694 Sales and marketing 1,493 2,599 2,958 5,255 Bad debt (recovery) expense ( 4,236 ) 68 ( 4,169 ) ( 23 ) Insurance recovery for property and equipment ( 871 ) — ( 871 ) — Total $ 24,060 $ 30,476 $ 52,068 $ 58,206

Revenue, Net (Tables)

Revenue, Net (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Summary of Disaggregated Revenue	The Company’s disaggregated net revenue by source, primarily due to the Company’s contracts with its external customers was as follows: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Retail $ 53,240 $ 58,254 $ 107,098 $ 113,676 Wholesale 24,283 13,870 51,058 27,846 Total $ 77,523 $ 72,124 $ 158,156 $ 141,522

Finance and Other Expenses (Tab

Finance and Other Expenses (Tables)	6 Months Ended
	Jun. 30, 2024
Finance And Other Expenses [Abstract]
Schedule of Finance and Other Expenses	The Company’s finance and other exp enses included the following: For the Three Months Ended For the Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 Interest and accretion $ 9,132 $ 7,965 $ 18,004 $ 15,840 Employee retention credits and transfer fee — — — 2,235 Other income ( 241 ) 206 ( 524 ) 183 Total $ 8,891 $ 8,171 $ 17,480 $ 18,258

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Schedule of Segment Information by Geographical Areas	The Company had non-current assets by geography of: June 30, 2024 December 31, 2023 United States $ 554,839 $ 562,854 Canada 598 775 Total $ 555,437 $ 563,629

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Summary of Financial Instruments Measured at Fair Value	The following table represents the fair value amounts of financial assets and financial liabilities measured at estimated fair value on a recurring basis: At June 30, 2024 At December 31, 2023 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets Cash and cash equivalents $ 27,378 — — $ 22,241 — — Restricted cash 3,113 — — 3,106 — — Total Assets $ 30,491 — — $ 25,347 — $ — Liabilities Contingent consideration payable — 4,741 — — 2,012 4,434 Detachable warrants — 2,253 — — 3,332 — Bifurcated conversion options — 899 — — 1,830 — Total Liabilities $ — $ 7,893 $ — $ — $ 7,174 $ 4,434
Summary of Changes in Derivative Liability	The following table summarizes the changes in the derivative liability for t he six months ended June 30, 2024: Balance at December 31, 2023 $ 5,162 Fair value gain on revaluation of warrants and conversion option ( 1,939 ) Effects of movements in foreign exchange ( 71 ) Balance at June 30, 2024 $ 3,152
Key Inputs and Assumptions Used in Black Scholes Simulation Model	The fair value of the various stock options granted were estimated using the Black-Scholes Model with the following assumptions: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. 1.91 - 2.89 1.71 - 2.81 Volatility 77.70 % - 78.31 % 77.79 % - 80.16 % Risk-free interest rate 3.18 % - 3.76 % 2.85 % - 4.26 % Expected life (years) 4.01 - 10.01 9.78 - 10.01 Dividend yield 0.00 % 0.00 % Forfeiture rate 26.11 % 26.11 %
Peninsula Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Summary of Fair Value of Contingent Consideration	The fair value of the Peninsula Contingent Consideration was calculated using the Black-Scholes Model. Key inputs and assumptions were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 1.65 $ 1.65 Annual volatility 83.1 % 63.3 % Annual risk-free rate 5.33 % 4.73 % Expected term (in years) 0.50 0.99
State Flower and The Apothecarium Contingent Consideration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Summary of Fair Value of Contingent Consideration	The fair value of the State Flower and The Apothecarium Contingent Considerations were calculated using the Black-Scholes Model. Key inputs and assumptions were as follows: June 30, 2024 January 19, 2024 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.95 Option exercise price $ 1.76 $ 1.76 Annual volatility 83.1 % 68.7 % Annual risk-free rate 5.33 % 5.21 % Expected term (in years) 1.56 2.00
Detachable Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Summary Of Warrant Liability Measured At Fair Value	The detachable warrants issued as a part of the June 2023 private placement (Note 13) have been measured at fair value as of June 30, 2024. Key inputs and assumptions used in the Black-Scholes Model were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 1.95 $ 1.95 Annual volatility 74.9 % 74.7 % Annual risk-free rate 5.09 % 4.23 % Expected term (in years) 0.98 1.48
Bifurcated Conversion Options
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Key Inputs and Assumptions Used in Black Scholes Simulation Model	The conversion option issued as a part of the June and August 2023 private placement (Note 12) has been measured at fair value as of June 30, 2024. Key inputs and assumptions used in the Black-Scholes Model were as follows: June 30, 2024 December 31, 2023 Common Stock Price of TerrAscend Corp. $ 1.35 $ 1.63 Option exercise price $ 2.01 $ 2.01 Annual volatility 77.0 % 70.1 % Annual risk-free rate 4.71 % 4.23 % Expected term (in years) 1.98 - 2.09 2.48 - 2.59

Nature of Operations - Addition

Nature of Operations - Additional Information (Details)	6 Months Ended
	Jun. 30, 2024 Dispensary Facility
Revenues from External Customers and Long-Lived Assets [Line Items]
Entity date of incorporation	Mar. 07, 2017
New Jersey
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of majority owned operation in dispensaries | Dispensary	3
Number of cultivation/processing facility owned | Facility	1
Maryland
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of majority owned operation in dispensaries | Dispensary	4
Number of cultivation/processing facility owned | Facility	1
Pennsylvania
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of majority owned operation in dispensaries | Dispensary	6
Number of cultivation/processing facility owned | Facility	1
Michigan
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of majority owned operation in dispensaries | Dispensary	20
Number of cultivation/processing facility owned | Facility	3
California
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of majority owned operation in dispensaries | Dispensary	4
Number of cultivation/processing facility owned | Facility	3

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) - Subsequent Event [Member] - USD ($) $ in Thousands	Aug. 01, 2024	Jul. 01, 2024
Debt Instrument [Line Items]
Principal amount		$ 115,998
Senior Secured Term Loan [Member]
Debt Instrument [Line Items]
Principal amount	$ 140,000
Debt Instrument Initial Draw Amount	114,000
Debt instrument delayed draw amount	$ 26,000

Consolidation - Additional Info

Consolidation - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2024
Noncontrolling Interest [Line Items]
Aggregate gross proceeds from private placement	$ 19,218
TerrAscend Growth
Noncontrolling Interest [Line Items]
Ownership interest		12.50%
TerrAscend Growth | Class A shares
Noncontrolling Interest [Line Items]
Aggregate gross proceeds from private placement	$ 1,000
TerrAscend Growth | Class B shares
Noncontrolling Interest [Line Items]
Ownership interest		99.80%
Canadian Business
Noncontrolling Interest [Line Items]
Ownership interest		95%

Accounts Receivable, net - Sche

Accounts Receivable, net - Schedule of Accounts Receivable, net (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Trade receivables	$ 16,811	$ 28,403
Sales tax receivable	617	408
Other receivables	530	1,154
Provision for current expected credit losses	(1,159)	(10,917)
Total receivables, net	$ 16,799	$ 19,048

Accounts Receivable, net - Sc_2

Accounts Receivable, net - Schedule of Trade Receivables (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Trade receivables	$ 16,811	$ 28,403
Less: provision for current expected credit losses	(1,159)	(10,917)
Total trade receivables, net	15,652	17,486
Current	12,023	13,799
31-90 days	2,035	2,837
Over 90 days	$ 2,753	$ 11,767

Accounts Receivable, net - Addi

Accounts Receivable, net - Additional Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Bad debt recovery	$ 4,188

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($) shares
Business Acquisition [Line Items]
Total consideration in cash	$ 4,925
State Flower and The Apothecarium Businesses
Business Acquisition [Line Items]
Number of common stock issued | shares	2,888,088
Total consideration in cash	$ 250

Acquisitions - Schedule of Bala

Acquisitions - Schedule of Balances of Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Dec. 31, 2023
Asset Acquisition Contingent Consideration [Line Items]
Carrying amount, Beginning balance		$ 6,446
Settlement of contingent consideration		(4,925)
Loss on revaluation of contingent consideration	$ 1,827	3,220
Carrying amount, Ending balance	4,741	4,741
Less: current portion	(2,632)	(2,632)	$ (6,446)
Non-current contingent consideration	2,109	2,109
State Flower
Asset Acquisition Contingent Consideration [Line Items]
Carrying amount, Beginning balance		1,406
Settlement of contingent consideration		(1,334)
Loss on revaluation of contingent consideration		705
Carrying amount, Ending balance	777	777
Less: current portion	0	0
Non-current contingent consideration	777	777
Apothecarium
Asset Acquisition Contingent Consideration [Line Items]
Carrying amount, Beginning balance		3,028
Settlement of contingent consideration		(3,591)
Loss on revaluation of contingent consideration		1,895
Carrying amount, Ending balance	1,332	1,332
Less: current portion	0	0
Non-current contingent consideration	1,332	1,332
Peninsula
Asset Acquisition Contingent Consideration [Line Items]
Carrying amount, Beginning balance		2,012
Settlement of contingent consideration		0
Loss on revaluation of contingent consideration		620
Carrying amount, Ending balance	2,632	2,632
Less: current portion	(2,632)	(2,632)
Non-current contingent consideration	$ 0	$ 0

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Inventory, Net [Abstract]
Raw materials	$ 552	$ 378
Finished goods	19,636	18,821
Work in process	26,953	28,451
Accessories, supplies and consumables	3,868	4,033
Total inventory	$ 51,009	$ 51,683

Discontinued Operations - Summa

Discontinued Operations - Summary of Results of Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Other expense
Net loss from discontinued operations	$ (621)	$ (4,212)
Discontinued Operations
Operating expenses:
General and administrative	455	756
Amortization and depreciation		48
Impairment of property and equipment		3,064
Total operating expenses	455	3,868
Loss from discontinued operations	(455)	(3,868)
Other expense
Finance and other expenses	166	344
Net loss from discontinued operations	$ (621)	$ (4,212)

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details)	Jun. 30, 2024 ft²
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Facility held for sale	67,300

Property and Equipment - Compon

Property and Equipment - Components of Property and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Total cost	$ 231,913	$ 229,101
Less: accumulated depreciation	(38,573)	(32,886)
Property and equipment, net	193,340	196,215
Land
Property Plant And Equipment [Line Items]
Total cost	6,152	6,103
Assets in Process
Property Plant And Equipment [Line Items]
Total cost	19,130	24,211
Buildings and Improvements
Property Plant And Equipment [Line Items]
Total cost	159,186	151,989
Machinery & Equipment
Property Plant And Equipment [Line Items]
Total cost	36,146	35,370
Office Furniture & Equipment
Property Plant And Equipment [Line Items]
Total cost	9,185	9,066
Assets under Finance Leases
Property Plant And Equipment [Line Items]
Total cost	$ 2,114	$ 2,362

Property and Equipment - Additi

Property and Equipment - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Impairment loss of property and equipment			$ 2,438,000	$ 28,000
Property and equipment, capitalized borrowing costs			0		$ 0
Depreciation expense	$ 3,055,000	$ 3,395,000	6,092,000	6,652,000
Cost of Sales
Property Plant And Equipment [Line Items]
Depreciation expense	$ 2,079,000	$ 2,023,000	$ 4,140,000	$ 4,040,000

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Intangible Assets [Line Items]
Finite lived intangible assets, Gross Carrying Amount	$ 190,568	$ 190,098
Finite lived intangible assets, Accumulated Amortization	(25,025)	(22,360)
Finite lived intangible assets, Net Carrying Amount	165,543	167,738
Indefinite lived intangible assets, Net Carrying Amount	46,972	48,116
Intangible assets net, Gross Carrying Amount	237,540	238,214
Intangible assets net, Accumulated Amortization	(25,025)	(22,360)
Intangible assets, net	212,515	215,854
Brand Intangibles
Intangible Assets [Line Items]
Indefinite lived intangible assets, Net Carrying Amount	46,972	48,116
Software
Intangible Assets [Line Items]
Finite lived intangible assets, Gross Carrying Amount	2,529	2,050
Finite lived intangible assets, Accumulated Amortization	(1,714)	(720)
Finite lived intangible assets, Net Carrying Amount	815	1,330
Licenses
Intangible Assets [Line Items]
Finite lived intangible assets, Gross Carrying Amount	187,759	186,624
Finite lived intangible assets, Accumulated Amortization	(23,031)	(20,216)
Finite lived intangible assets, Net Carrying Amount	164,728	166,408
Brand Intangibles
Intangible Assets [Line Items]
Finite lived intangible assets, Gross Carrying Amount		1,144
Finite lived intangible assets, Accumulated Amortization		(1,144)
Non-Compete Agreements
Intangible Assets [Line Items]
Finite lived intangible assets, Gross Carrying Amount	280	280
Finite lived intangible assets, Accumulated Amortization	$ (280)	$ (280)

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Segment	Jun. 30, 2023 USD ($)
Intangible Assets [Line Items]
Amortization expense	$ 1,941	$ 1,595	$ 3,872	$ 3,109
Weighted average amortization period	25 years		25 years
Number of reportable segment | Segment			1
Cost of Sales
Intangible Assets [Line Items]
Amortization expense	$ 724	$ 725	$ 1,448	$ 1,450

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Estimated Future Amortization Expense for Finite Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 3,684
2025	7,253
2026	7,242
2027	7,164
2028	7,112
Thereafter	133,088
Finite lived intangible assets, Net Carrying Amount	$ 165,543	$ 167,738

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Activity in Goodwill Balance (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Balance at December 31, 2023	$ 106,929
Additions at acquisition date	0
Measurement period adjustment	0
Balance at June 30, 2024	$ 106,929

Loans Payable - Schedule of Loa

Loans Payable - Schedule of Loans Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Net carrying amount	$ 187,872	$ 199,370
Short-term debt	6,244	11,849
Current portion of long-term debt	9,702	125,888
Loans payable, current - prior to refinancing	15,946	137,737
Loans payable, non-current - prior to refinancing	171,926	61,633
Maryland Acquisition Loans
Debt Instrument [Line Items]
Principal amount	19,115	19,873
Unamortized discount	(1,065)	(1,403)
Net carrying amount	18,050	18,470
Chicago Atlantic Term Loan
Debt Instrument [Line Items]
Principal amount	24,196	24,611
Net carrying amount	24,196	24,611
Ilera Term Loan
Debt Instrument [Line Items]
Principal amount	68,927	76,927
Deferred financing cost	(1,552)	(3,191)
Net carrying amount	67,375	73,736
Stearns Loan
Debt Instrument [Line Items]
Principal amount	24,638	24,809
Deferred financing cost	(426)	(791)
Net carrying amount	24,212	24,018
Pelorus Term Loan
Debt Instrument [Line Items]
Principal amount	45,478	45,478
Deferred financing cost	(1,334)	(1,490)
Net carrying amount	44,144	43,988
Other Loans
Debt Instrument [Line Items]
Net carrying amount	$ 3,651	$ 2,698

Loans Payable - Schedule of L_2

Loans Payable - Schedule of Loans Payable (Parenthetical) (Details) - USD ($) $ in Thousands		6 Months Ended
	Jul. 01, 2024	Jun. 30, 2024	Aug. 01, 2024	Dec. 31, 2023
Subsequent Event
Debt Instrument [Line Items]
Principal amount	$ 115,998
Subsequent Event | Maximum
Debt Instrument [Line Items]
Debt instrument maturity month and year	2028-08
Chicago Atlantic Term Loan
Debt Instrument [Line Items]
Principal amount		$ 24,196		$ 24,611
Debt instrument maturity month and year		2024-11
Chicago Atlantic Term Loan | Subsequent Event
Debt Instrument [Line Items]
Principal amount			$ 22,696
Ilera Term Loan
Debt Instrument [Line Items]
Principal amount		$ 68,927		76,927
Debt instrument maturity month and year		2024-12
Ilera Term Loan | Subsequent Event
Debt Instrument [Line Items]
Principal amount			$ 68,927
Stearns Loan
Debt Instrument [Line Items]
Principal amount		$ 24,638		24,809
Debt instrument maturity month and year		2024-12
Pelorus Term Loan
Debt Instrument [Line Items]
Principal amount		$ 45,478		$ 45,478
Debt instrument maturity month and year		2027-10

Loans Payable - Additional Info

Loans Payable - Additional Information (Details) - USD ($) $ in Thousands

3 Months Ended

6 Months Ended

Jul. 19, 2024

Jul. 01, 2024

Apr. 30, 2024

Jan. 15, 2024

Jan. 02, 2024

Jun. 26, 2023

Apr. 20, 2023

Oct. 11, 2022

Dec. 18, 2020

Jun. 30, 2024

Jun. 30, 2023

Jun. 30, 2024

Jun. 30, 2023

Aug. 01, 2024

Dec. 31, 2023

Mar. 10, 2022

Debt Instrument [Line Items]

Total interest paid on all loan payables

$ 6,335

$ 6,803

$ 12,599

$ 9,259

Interest payable on loan payable, current

$ 3,261

3,261

$ 3,491

Prepayment of term loan

$ 18,048

$ 40,359

Weighted-Average Interest Rate

11.06%

11.06%

Short-term debt, average amount

$ 8,727

Subsequent Event

Debt Instrument [Line Items]

Principal amount

$ 115,998

Senior Secured Term Loan | Subsequent Event

Debt Instrument [Line Items]

Principal amount

$ 140,000

Stearns Loan

Debt Instrument [Line Items]

Principal amount

$ 25,000

$ 24,638

24,638

Debt instrument maturity date

Dec. 26, 2024

Stearns Loan | Subsequent Event

Debt Instrument [Line Items]

Principal amount

24,638

Senior secured term loan fair value

140,000

Pelorus Term Loan

Debt Instrument [Line Items]

Principal amount

$ 45,478

45,478

45,478

Debt instrument maturity date

Oct. 11, 2027

Interest-only payments term

36 months

Other Loans

Debt Instrument [Line Items]

Principal amount

936

936

IHC Real Estate LP Loan

Debt Instrument [Line Items]

Payment of notes

$ 5,000

Class A shares | TerrAscend Growth

Debt Instrument [Line Items]

Principal amount

1,715

Precentage of guaranteed annual dividend

20%

Subcription Amount Percentage

40%

Senior secured term loan fair value

140,000

Share issued

$ 1,000

Maryland Acquisition Loans

Debt Instrument [Line Items]

Principal amount

19,115

19,115

19,873

Maryland Acquisition Loans | Promissory Notes 7.0% to 10.5%

Debt Instrument [Line Items]

Principal amount

20,625

$ 20,625

Debt instrument maturity date

Jun. 30, 2027

Prime Rate | Stearns Loan

Debt Instrument [Line Items]

Interest rate

2.25%

Prime Rate | Pelorus Term Loan

Debt Instrument [Line Items]

Debt instrument, variable rate

2.50%

Effective federal funds rate

0.50%

Secured overnight financing rate (SOFR) | Pelorus Term Loan

Debt Instrument [Line Items]

Debt instrument, variable rate

9.50%

Ilera Term Loan

Debt Instrument [Line Items]

Percentage of prepayment price

100%

100%

Principal amount

$ 68,927

$ 68,927

76,927

Debt instrument maturity month and year

2024-12

Prepayment of term loan

$ 3,200

$ 4,800

Ilera Term Loan | Subsequent Event

Debt Instrument [Line Items]

Principal amount

68,927

Senior secured term loan fair value

140,000

Ilera Term Loan | Ilera | Senior Secured Term Loan

Debt Instrument [Line Items]

Principal amount

$ 120,000

Interest rate

12.875%

Debt instrument maturity date

Dec. 17, 2024

Gage Loan

Debt Instrument [Line Items]

Interest rate

6%

6%

Senior secured term loan fair value

$ 25,000

Promissory note acquisition date fair value

$ 4,065

Debt instrument maturity date

Nov. 01, 2024

Gage Loan | Promissory Note at 6%

Debt Instrument [Line Items]

Debt instrument maturity date

Dec. 31, 2024

Chicago Atlantic Term Loan

Debt Instrument [Line Items]

Principal amount

$ 24,196

$ 24,196

$ 24,611

Debt instrument maturity month and year

2024-11

Chicago Atlantic Term Loan | Subsequent Event

Debt Instrument [Line Items]

Principal amount

22,696

Senior secured term loan fair value

$ 140,000

Prepayment of term loan

$ 1,500

Minimum | Maryland Acquisition Loans | Promissory Notes 7.0% to 10.5%

Debt Instrument [Line Items]

Interest rate

7%

7%

Minimum | Gage Loan | Prime Rate

Debt Instrument [Line Items]

Credit agreement bears interest rate

6%

Maximum | Subsequent Event

Debt Instrument [Line Items]

Debt instrument maturity month and year

2028-08

Maximum | Maryland Acquisition Loans | Promissory Notes 7.0% to 10.5%

Debt Instrument [Line Items]

Interest rate

10.50%

10.50%

Maximum | Gage Loan | Prime Rate

Debt Instrument [Line Items]

Credit agreement bears interest rate

13%

Loans payable - Summary of Stat

Loans payable - Summary of Stated maturities of Loans Payable (Details) $ in Thousands	Jun. 30, 2024 USD ($)
Debt Disclosure [Abstract]
2024	$ 9,449
2025	7,942
2026	10,771
2027	44,483
2028	118,980
Long-term Debt, Total	$ 191,625

Leases - Additional Information

Leases - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Leases	Jun. 30, 2023 USD ($)	Dec. 31, 2023 Leases
Lessee Lease Description [Line Items]
Number of finance lease | Leases			2		2
Operating lease expense | $	$ 2,204	$ 1,254	$ 4,024	$ 2,451
Minimum
Lessee Lease Description [Line Items]
Operating lease term	1 year		1 year
Maximum
Lessee Lease Description [Line Items]
Operating lease term	25 years		25 years

Leases - Summary of Amounts Rec

Leases - Summary of Amounts Recognized in Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Operating leases:
Operating lease right-of-use assets	$ 41,645	$ 43,440
Operating lease liability classified as current	2,330	1,244
Operating lease liability classified as non-current	42,654	45,384
Total operating lease liabilities	44,984	46,628
Finance leases:
Property and equipment, net	$ 1,792	$ 2,112
Finance lease, right-of-use asset, statement of financial position [extensible enumeration]	Property and equipment, net	Property and equipment, net
Lease obligations under finance leases classified as current	$ 93	$ 2,030
Lease obligations under finance leases classified as non-current	2,140	407
Total finance lease obligations	$ 2,233	$ 2,437

Leases - Summary of Other Infor

Leases - Summary of Other Information Related to Operating Leases (Details)	Jun. 30, 2024	Dec. 31, 2023
Weighted-average remaining lease term (years)
Operating leases	12 years 3 months 18 days	12 years 6 months
Finance leases	1 year 9 months 18 days	1 year 2 months 12 days
Weighted-average discount rate
Operating leases	11.42%	11.43%
Finance leases	9.47%	9.47%

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Cash paid for amounts included in measurement of operating lease liabilities	$ 3,720	$ 6,264
Right-of-use assets obtained in exchange for lease obligations	509	16,603
Cash paid for amounts included in measurement of finance lease liabilities	$ 65	$ 153

Leases - Summary of Undiscounte

Leases - Summary of Undiscounted Lease Obligations (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Operating, 2024	$ 3,597
Operating, 2025	7,278
Operating, 2026	7,051
Operating, 2027	6,933
Operating, 2028	6,730
Operating, Thereafter	55,773
Operating, Total lease payments	87,362
Operating, Less: interest	(42,378)
Operating, Total lease liabilities	44,984	$ 46,628
Finance, 2024	65
Finance, 2025	2,132
Finance, 2026	134
Finance, 2027	136
Finance, 2028	80
Finance, Total lease payments	2,547
Finance, Less: interest	(314)
Finance, Total lease liabilities	2,233	$ 2,437
2024	3,662
2025	9,410
2026	7,185
2027	7,069
2028	6,810
Thereafter	55,773
Total lease payments	89,909
Less: interest	(42,692)
Total lease liabilities	$ 47,217

Convertible Debt - Summary Of C

Convertible Debt - Summary Of Convertible Debt (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Interest and accretion	$ 6,335	$ 6,803	$ 12,599	$ 9,259
Convertible debt - Maturing June 2026
Debt Instrument [Line Items]
Convertible debt proceeds, net of transaction costs - Maturing June 2026			10,098		$ 10,098
Allocation to conversion option			3,600		3,600
Allocation to debt			6,498		6,498
Interest and accretion			1,628		768
Net carrying amount	$ 8,126		$ 8,126		$ 7,266

Convertible Debt - Additional I

Convertible Debt - Additional Information (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Accounts payable and accrued liabilities
Short-Term Debt [Line Items]
Accrued interest on convertible debt	$ 778,000	$ 0

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Outstanding Warrants (Details) - Common Stock - $ / shares	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Class Of Warrant Or Right [Line Items]
Number of Warrants Outstanding, Beginning balance	23,330,542
Number of Warrants Outstanding, Granted	344,140
Number of Warrants Outstanding, Expired	0
Number of Warrants Outstanding, Ending balance	23,674,682
Number of Warrants Exercisable	818,927
Number of Warrants Exercisable	344,140
Number of Warrants Exercisable	0
Number of Warrants Exercisable	1,163,067
Weighted Average Exercise Price	$ 4.56
Weighted Average Exercise Price	2.17
Weighted Average Exercise Price	0
Weighted Average Exercise Price	$ 4.37
Weighted Average Remaining Life (years), Granted	3 years 3 days
Weighted Average Remaining Life (years)	8 years 2 months 1 day	8 years 8 months 26 days
Gage Growth Corp
Class Of Warrant Or Right [Line Items]
Number of Warrants Outstanding, Beginning balance	3,590,334
Number of Warrants Outstanding, Ending balance	3,590,334
Weighted Average Exercise Price	$ 1.95
Weighted Average Exercise Price	$ 1.95
Weighted Average Remaining Life (years)	11 months 23 days	1 year 5 months 23 days

Share-Based Compensation Plan_2

Share-Based Compensation Plans - Total Share-Based Payments Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation	$ 1,960	$ 1,981	$ 3,445	$ 3,694
Stock Options
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation	1,183	1,437	2,087	2,697
Restricted Share Units
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation	$ 777	$ 544	$ 1,358	$ 997

Share-Based Compensation Plan_3

Share-Based Compensation Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Number of Stock Options, Outstanding at beginning of period	16,278,380
Number of Stock Options, Granted	1,845,000
Number of Stock Options, Exercised	(25,000)
Number of Stock Options, Forfeited	(420,354)
Number of Stock Options, Expired	(1,707,057)
Number of Stock Options, Outstanding at end of period	15,970,969	16,278,380
Number of Stock Options, Exercisable at June 30, 2024	11,313,294
Number of Stock Options, Nonvested at June 30, 2024	4,657,675
Weighted average remaining contractual life (in years), Outstanding	5 years 5 months 19 days	4 years 8 months 26 days
Weighted average remaining contractual life (in years), Exercisable	4 years 2 months 15 days
Weighted average remaining contractual life (in years), Nonvested	8 years 6 months 7 days
Weighted Average Exercise Price (per share), Outstanding at beginning of period	$ 3.35
Weighted Average Exercise Price (per share), Granted	2.82
Weighted Average Exercise Price (per share), Exercised	1.6
Weighted Average Exercise Price (per share), Forfeited	2.35
Weighted Average Exercise Price (per share), Expired	3.48
Weighted Average Exercise Price (per share), Outstanding at end of period	3.36	$ 3.35
Weighted Average Exercise Price (per share), Exercisable at June 30, 2024	3.63
Weighted Average Exercise Price (per share), Nonvested at June 30, 2024	$ 2.68
Aggregate intrinsic value, Outstanding at beginning of period	$ 658
Aggregate intrinsic value, Outstanding at end of period	243	$ 658
Aggregate intrinsic value, Exercisable at June 30, 2024	165
Aggregate intrinsic value, Nonvested at June 30, 2024	$ 78

Share-Based Compensation Plan_4

Share-Based Compensation Plans - Summary of Stock Options Exercised (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Exercised	$ 5	$ 5	$ 551

Share-Based Compensation Plan_5

Share-Based Compensation Plans - Summary of Weighted-average Assumptions used to Estimate Fair Value of Various Stock Options Granted (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Volatility minimum	77.70%	77.79%
Volatility maximum	78.31%	80.16%
Risk-free interest rate minimum	3.18%	2.85%
Risk-free interest rate maximum	3.76%	4.26%
Dividend yield	0%	0%
Forfeiture rate	26.11%	26.11%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common Stock Price of TerrAscend Corp.	$ 1.91	$ 1.71
Expected life (years)	4 years 3 days	9 years 9 months 10 days
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common Stock Price of TerrAscend Corp.	$ 2.89	$ 2.81
Expected life (years)	10 years 3 days	10 years 3 days

Share-Based Compensation Plan_6

Share-Based Compensation Plans - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total estimated fair value of stock options vested	$ 4,594	$ 5,563
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation cost related to unvested options	7,658
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation cost related to unvested RSUs	$ 4,194

Share-Based Compensation Plan_7

Share-Based Compensation Plans - Summary of Activities for Unvested RSUs (Details)	6 Months Ended
	Jun. 30, 2024 shares
Share-Based Payment Arrangement [Abstract]
Number of RSUs, Outstanding at beginning of period	1,078,584
Number of RSUs, Granted	2,234,612
Number of RSUs, Vested	(336,037)
Number of RSUs, Forfeited	(162,090)
Number of RSUs, Outstanding at end of period	2,815,069

Non-controlling interest - Addi

Non-controlling interest - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 19, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests		$ (4,674)	$ 7,500
California
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	$ 1,374
TerrAscend Growth
Noncontrolling Interest [Line Items]
Ownership interest				12.50%
State Flower and three Apothecarium | California
Noncontrolling Interest [Line Items]
Acquisition of the remaining equity	50.10%

Noncontrolling Interest - Sched

Noncontrolling Interest - Schedule of Ownership in Minority Interest (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	12 Months Ended
	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Noncontrolling Interest [Line Items]
Opening carrying amount balance	$ (1,756)		$ (1,756)	$ 2,374
Capital contributions received			(2,283)	(11,622)
Acquisition of non-controlling interest	$ 4,674	$ (7,500)
Net income attributable to non-controlling interest			4,147	8,815
Ending carrying amount balance			1,482	(1,756)
IHC Real Estate | Pennsylvania
Noncontrolling Interest [Line Items]
Acquisition of non-controlling interest			$ 1,374	$ (1,323)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Income Tax Disclosure [Line Items]
Effective tax rate	(101.00%)		(148.00%)
Unrecognized tax benefits		$ 134,709		$ 84,485
Unrecognized tax benefits amounts		12,772		10,459
Unrecognized tax benefits other long term liabilities		$ 1,130		$ 4,667
Uncertain tax positions description		The Company recognizes benefits from uncertain tax positions based on the cumulative probability method whereby the largest benefit with a cumulative probability of greater than 50% is recorded. An uncertain tax position is not recognized if it has less than a 50% likelihood of being sustained.
Federal tax return refund		$ 8,371

Income Taxes -Schedule of Recon

Income Taxes -Schedule of Reconciliation of Unrecognized Tax Benefits (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Income Tax Disclosure [Abstract]
Balance, beginning of period	$ 84,485
Increases based on tax positions related to prior years	32,976
Additions based on tax positions related to the current year	17,248
Decreases related to settlements / expirations	0
Ending carrying amount	$ 134,709

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Uncertain Tax Liabilities, Inclusive of Accruals for Related Penalties and Interest (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract]
Balance, beginning of period	$ 77,084
Increases based on tax positions related to prior years	6,899
Additions based on tax positions related to the current year	16,081
Additions based on refunds received related to prior years	8,371
Reclass of tax payments on deposit	1,108
Ending carrying amount	$ 109,543

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Related Party
Related Party Transaction [Line Items]
Loan principal balance	$ 142	$ 159

General and Administrative Ex_3

General and Administrative Expenses - Summary of General and Administrative Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
General And Administrative Expense [Line Items]
Share-based compensation	$ 1,960	$ 1,981	$ 3,445	$ 3,694
General and Administrative Expense
General And Administrative Expense [Line Items]
Office and general	3,662	3,733	7,551	7,828
Professional fees	3,840	5,103	6,901	8,476
Lease expense	2,204	1,294	4,024	2,538
Facility and maintenance	1,034	1,364	2,359	2,608
Salaries and wages	14,974	14,334	29,870	27,830
Share-based compensation	1,960	1,981	3,445	3,694
Sales and marketing	1,493	2,599	2,958	5,255
Bad debt (recovery) expense	(4,236)	68	(4,169)	(23)
Insurance recovery for property and equipment	(871)		(871)
Total	$ 24,060	$ 30,476	$ 52,068	$ 58,206

Revenue, Net - Summary of Disag

Revenue, Net - Summary of Disaggregated Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation Of Revenue [Line Items]
Revenue	$ 77,523	$ 72,124	$ 158,156	$ 141,522
Retail
Disaggregation Of Revenue [Line Items]
Revenue	53,240	58,254	107,098	113,676
Wholesale
Disaggregation Of Revenue [Line Items]
Revenue	$ 24,283	$ 13,870	$ 51,058	$ 27,846

Revenue, Net - Additional Infor

Revenue, Net - Additional Information (Details) - Customer	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Number of customers accounting more than 10% of revenue	0	0	0	0

Finance and Other Expenses - Sc

Finance and Other Expenses - Schedule of Finance and Other Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Finance And Other Expenses [Abstract]
Interest and accretion	$ 9,132	$ 7,965	$ 18,004	$ 15,840
Employee retention credits and transfer fee				2,235
Other income	(241)	206	(524)	183
Total	$ 8,891	$ 8,171	$ 17,480	$ 18,258

Segment Information - Additiona

Segment Information - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Segment	Jun. 30, 2023 USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of operating segment | Segment			1
Net revenue	$ 77,523	$ 72,124	$ 158,156	$ 141,522
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	$ 274		$ 538

Segment Information - Schedule

Segment Information - Schedule of Segment Information by Geographical Areas (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Revenues From External Customers And Long Lived Assets [Line Items]
Non-current assets	$ 555,437	$ 563,629
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Non-current assets	554,839	562,854
Canada
Revenues From External Customers And Long Lived Assets [Line Items]
Non-current assets	$ 598	$ 775

Financial Instruments and Ris_3

Financial Instruments and Risk Management - Summary of Financial Instruments Measured at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Contingent consideration payable	$ 4,741	$ 6,446
Derivative liability	3,152	5,162
Fair Value, Measurements, Recurring | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash and cash equivalents	27,378	22,241
Restricted cash	3,113	3,106
Total Assets	30,491	25,347
Fair Value, Measurements, Recurring | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Contingent consideration payable	4,741	2,012
Detachable warrants	2,253	3,332
Bifurcated coversion options	899	1,830
Total Liabilities	$ 7,893	7,174
Fair Value, Measurements, Recurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Contingent consideration payable		4,434
Total Liabilities		$ 4,434

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Additional Information (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair value assets transfers between levels of hierarchy	$ 0	$ 0

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Summary of Changes in Derivative Liability (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Fair Value Disclosures [Abstract]
Balance at December 31, 2023	$ 5,162
Fair value gain on revaluation of warrants and conversion option	(1,939)
Effects of movements in foreign exchange	(71)
Balance at June 30, 2024	$ 3,152

Financial Instruments and Ris_6

Financial Instruments and Risk Management - Key Inputs and Assumptions Used in Black Scholes Simulation Model (Details)		6 Months Ended	12 Months Ended
	Jan. 19, 2024 $ / shares	Jun. 30, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Annual volatility, minimum		77.70%	77.79%
Annual volatility, maximum		78.31%	80.16%
Annual risk-free rate, minimum		3.18%	2.85%
Annual risk-free rate, maximum		3.76%	4.26%
Peninsula Contingent Consideration
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp.		$ 1.35	$ 1.63
Option exercise price		$ 1.65	$ 1.65
Annual volatility		83.10%	63.30%
Annual risk-free rate		5.33%	4.73%
Expected term (in years)		6 months	11 months 26 days
State Flower and The Apothecarium Contingent Consideration
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp.	$ 1.95	$ 1.35
Option exercise price	$ 1.76	$ 1.76
Annual volatility	68.70%	83.10%
Annual risk-free rate	5.21%	5.33%
Expected term (in years)	2 years	1 year 6 months 21 days
Minimum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp.		$ 1.91	$ 1.71
Expected term (in years)		4 years 3 days	9 years 9 months 10 days
Maximum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp.		$ 2.89	$ 2.81
Expected term (in years)		10 years 3 days	10 years 3 days
Detachable Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp. | $		1.35	1.63
Option exercise price		$ 1.95	$ 1.95
Annual volatility		74.90%	74.70%
Annual risk-free rate		5.09%	4.23%
Expected term (in years)		11 months 23 days	1 year 5 months 23 days
Bifurcated Conversion Options | June and August 2023 private placement
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Common Stock Price of TerrAscend Corp.		$ 1.35	$ 1.63
Option exercise price		$ 2.01	$ 2.01
Annual volatility		77%	70.10%
Annual risk-free rate		4.71%	4.23%
Bifurcated Conversion Options | June and August 2023 private placement | Minimum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Expected term (in years)		1 year 11 months 23 days	2 years 5 months 23 days
Bifurcated Conversion Options | June and August 2023 private placement | Maximum
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Expected term (in years)		2 years 1 month 2 days	2 years 7 months 2 days

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) $ in Thousands	Aug. 09, 2023 USD ($)
AEY Capital LLC
Loss Contingencies [Line Items]
Loss contingency, amount of damages sought	$ 14,969

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($) $ in Thousands				6 Months Ended
	Aug. 01, 2024	Jul. 31, 2024	Jul. 19, 2024	Jun. 30, 2024	Jun. 30, 2023	Jul. 01, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Prepayment of term loan				$ 18,048	$ 40,359
Subsequent Event
Subsequent Event [Line Items]
Principal amount						$ 115,998
Senior Secured Term Loan | Subsequent Event
Subsequent Event [Line Items]
Principal amount	$ 140,000
Debt instrument initial draw amount	114,000
Debt instrument delayed draw amount	26,000
Chicago Atlantic Term Loan
Subsequent Event [Line Items]
Principal amount				$ 24,196			$ 24,611
Chicago Atlantic Term Loan | Subsequent Event
Subsequent Event [Line Items]
Prepayment of term loan			$ 1,500
Principal amount	22,696
FG Loan | Subsequent Event
Subsequent Event [Line Items]
Invested amount by related party	7,500
FG Loan | Senior Secured Term Loan | Subsequent Event
Subsequent Event [Line Items]
Principal amount		$ 140,000
Debt instrument maturity period		4 years
Interest rate		12.75%
Debt instrument initial draw amount	114,000
Debt instrument delayed draw amount	$ 26,000